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Abstract 
Development of a drug delivery agent that selectively targets and destroys tumor cells with 
minimal toxicity to normal tissues is a major challenge in cancer therapy. It has been known 
for more than 60 years that anaerobic bacteria such as Clostridium can selectively colonize 
inside the necrotic core of solid tumors.  Inoculation of a tumor by wild type Clostridium results 
in colonization of the necrotic core and consequently significant tumor destruction.  This 
treatment strategy is hampered by the fact that the outer rim of the tumor is typically viable, 
and so does not present an anaerobic environment.  As a result, colonization by Clostridium is 
unlikely to lead to complete tumor regression, since tumor regrowth occurs from the remaining 
outer viable rim, as evidenced by clinical trials. This project aims to address the problem of 
regrowth by developing a novel selectively aerotolerant strain of Clostridium that cannot 
colonize inside healthy tissue, but that could grow in the viable rim of an infected tumor.  We 
have engineered a gene coding for an aerotolerance enzyme into Clostridium sporogenes. To 
couple the selective expression of this gene to tumor colonization, it can be placed under the 
control of a promoter activated by a synthetic quorum sensing circuit. This document describes 
the foundational work that will allow this system to be implemented. A suitable strain of C. 
sporogenes was selected, and a cloning technique (via conjugation with E. coli) was 
implemented. Expression of the aerotolerance enzyme and a synthetic quorum sensing circuit 
were verified in engineered colonies, and appropriate function was confirmed in both cases. 
Additionally, a model-based design exercise was carried out in order to better understand the 
system behavior and to identify key parameters for controlling the bacterial population. This 
analysis was based on mathematical models of the quorum-sensing circuit and of bacterial 
growth in the tumor environment. Sensitivity analysis reveals the design parameters that have 
the most significant impact on the extent and specificity of colonization of the viable rim, and 
thus provides insights into efficient design of the synthetic mechanism. 
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Chapter 1  
Introduction 
1.1 Motivation 
Bacteria-mediated cancer therapy has a long history. Almost two centuries ago it was observed that 
bacterial infections could cause tumor regression. In the 1860’s bacteria were used actively in cancer 
therapy and research on this area started in the mid 1930’s. Anaerobic bacteria can colonize inside the 
necrotic core of a solid tumor, which is oxygen free and rich in nutrition. Most of the research in this 
area has been focused on Salmonella and Clostridium, which have been identified as excellent choices 
for cancer therapy: Salmonella because it allows easy genetic manipulation, and Clostridium because 
it colonizes in large numbers in tumors [1,2,3]. 
 
Among the strains that have been investigated, Clostridium sporogenes seems to be one of the best in 
tumor targeting and colonization. This strain is motile, non-pathogenic, spore-forming, and colonizes 
selectively in tumors in large numbers. Colonization of wild-type C. sporogenes in the necrotic core of 
the tumor leads to significant tumor oncolysis, but regrowth occurs from the viable outer rim of the 
tumor, which is oxygenated[2]. The use of C. sporogenes for cancer therapy entered clinical trial in 
1967 [2] but was discontinued because of the regrowth problem. Since then, a number of alternative 
approaches, such as delivery of prodrug-converting enzymes, combined bacteria-radio therapy, and 
combined bacteria-chemo therapy have been explored in attempt to arrive at a successful therapy [1]. 
In 2006, the first successful gene transformation protocol for C. sporogenes opened a new window in 
bacteria mediated cancer therapy [4]. 
 
On the other hand, new techniques in synthetic biology help us to spatially and temporally control gene 
expression inside specific environments. The tumor regrowth problem can be solved using recombinant 
C. sporogenes and new techniques in synthetic biology, which allow for specific functions (e.g. 
aerotolerance, drug release) to be triggered selectively in the tumor environment.  
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1.2 Objective, Hypothesis and Methodology 
This project aims to address the problem of regrowth of tumor tissue after bacteriolytic treatment. 
Our goal is to develop a novel selectively aerotolerant strain of Clostridium that cannot colonize inside 
healthy tissue, but that could grow in the viable rim of an infected tumor. We hypothesize that 
aerotolerance is conferred by expression of an aerotolerance enzyme by an engineered strain of 
Clostridium sporogenes. To couple the selective expression of this gene to tumor colonization, it will 
be placed under the control of a promoter activated by a synthetic quorum sensing circuit.    
A synthetic biology approach is used in this project. The quorum sensing mechanism in gram positive 
and gram negative bacteria are modeled in details to understand the system behavior. System analysis 
on these models helps us understand the contribution of all components on system behavior. 
Additionally, modeling of colony growth in tumors and sensitivity analysis of this model reveals the 
design parameters that have the most significant impact on the extent and specificity of colonization 
within the viable rim, and thus provides insights into the design of the synthetic mechanism.  
We used conjugation to transfer genes into C. sporogenes. The lux promoter from Vibrio fischeri and 
the P2 and P3 promoters from Staphylococcus aureus were chosen as candidates to produce density 
dependent gene expression in C. sporogenes. In order to study the behavior of these promoters in C. 
sporogenes, they were cloned upstream of an anaerobic gene reporter with all associated quorum 
sensing elements. As a positive control, we assayed expression from the thiolase promoter (thl) from 
C. acetobutylicum. The three genetic circuits were transformed into C. sporogenes and their behavior 
was compared with the positive control and the native bacteria. The lux promoter showed no activity 
in C. sporogenes, but the P2 and P3 promoters were active. However, the P2 promoter showed behavior 
very similar to the constitutive expression. Expression from P3 was low at low cell concentrations and 
increased dramatically as the cell density crossed a threshold, demonstrating a switch-like behavior.  
Thus the P3 promoter seems to be a good candidate for cell density expression of an aerotolerance 
enzyme. 
The potential for aerotolerance of C. Sporogenes was addressed by measuring the effect of  
constitutive expression of the noxA gene from C. Aminovalericum, which express a water-forming  
NADPH oxidase.  The noxA gene was cloned upstream of the thl promoter, and  the resulting plasmid 
was transformed into C. sporogenes. The behavior of the engineered C. sporogenes strain was 
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compared with the native strain in the presence of oxygen. The engineered strain retained its growth 
while the native strain did not, suggesting that expression of noxA can make C. sporogenes aerotolerant.  
The planned final construct, an engineered C. sporogenes, expressing aerotolerance enzyme under 
the control of the quorum-sensing P3 promoter, may be capable of destroying the oxygenated part of a 
tumour, and thus providing a successful therapy. Moreover, this strain can be used as a safe vehicle to 
deliver therapeutic agents (gene, drugs, prodrugs) into the proliferating and non-proliferating part of 
the tumor. Because the expression of a single aerotolerance enzyme is not enough to significantly 
scavenge oxygen in fully oxygenated healthy tissue, there is minimal concern for the engineered colony 
to grow beyond the rim of the tumor. Moreover, any bacterial cells that escape the tumor environment 
will have to face the immune system (which is compromised in the tumor itself). 
To the best of our knowledge this is the first time that an attempt has been made to express 
of noxA in C. sporogenes, and the first time that a synthetic quorum sensing has been engineered in C. 
sporogenes. 
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Chapter 2 
Literature Review 
2.1 Introduction  
Almost 150 years ago bacterial infections was used actively for the first time to cure cancer patients 
[2,3].  Since that time, a range of bacterial strains, including E.coli, Bifidobacteria, Salmonela, and 
Clostridia, have been tested for tumor therapy. This chapter begins with a description of the tumor 
microenvironment in section 2.2, which will be followed by a review of research on clostridia-mediated 
and salmonella-mediated bacterial tumor therapy in sections 2.3.  
The therapeutic design proposed in this manuscript involves engineering a strain of Clostridium so 
that it will gain aerotolance when germinating to high density in solid tumors. A literature review of 
oxygen metabolism in Clostridium is reported in section 2.4. Section 2.5 describes the quorum sensing 
mechanism in gram positive and gram negative bacteria, which provides a means to implement density-
dependent behavior. Mathematical modelling of quorum sensing mechanism is reviewed in Section 2.6. 
Finally a brief overview  of synthetic biology is presented in Section 2.7. 
2.2 Tumor Microenvironment 
Every cell in the human body follows a highly regulated cell cycle. If a single cell loses its control 
over cell cycle, it could proliferate quickly and produce a vast population of cells,  resulting in formation 
of a tumor. As the tumor grows the surrounding blood vessels become inadequate to supply nutrients 
for the abnormal cells. This triggers the secretion of tumor angiogenic factors (TAFs). TAFs stimulate 
differentiation, division and migration of endothelial cells of the blood vessels to the tumor site. The 
imbalance between different TAFs typically causes abnormality in the blood vessels of the tumor. As 
the tumor grows the distance between microvessels and some tumor cells increases. As a consequence, 
the oxygen level of the inner part of the tumor is reduced. The low level of oxygen in the inner part of 
the tumor makes this part highly hypoxic. Some parts of the inner tumor become oxygen-free; cells in 
these areas undergo necrosis ([1,2]) .    
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Figure 1: Structure of solid tumors  
 
Figure 1 shows the structure of an idealized solid tumor.  In the proliferative part, the abnormal cells 
are close to blood vessels and receive sufficient nutrition and oxygen.  In the quiescent or hypoxic part, 
the concentration of oxygen is less than 0.33% (2.5 mmHg). (By comparison, the oxygen concentration 
in normal tissue ranges from 3.1-8.7% (24-66 mmHg)  [7,8].) The abnormal cells in this part of the 
tumor stop proliferating. The necrotic core of the tumor is composed of dead cells. The oxygen level in 
the necrotic core is almost zero.   
The lymphatic vessels in both the hypoxic and necrotic parts of the tumor are abnormal and cannot 
discharge waste water from inside the tumor. Therefore the interstitial pressure increases in these parts. 
The high interstitial pressure and low oxygen concentration make hypoxia a barrier against some 
traditional cancer therapy methods such as chemotherapy and radiotherapy [9].  
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2.3 Bacteria Mediated Cancer Therapy  
Even though hypoxia is a serious barrier against chemotherapy and radiotherapy, it can be used as a 
marker to distinguish solid tumors from normal tissues. Since the necrotic part of a tumor is oxygen-
free and rich in nutrients from dead cells, it is an ideal environment for anaerobic and facultative 
anaerobic bacteria to germinate.  Anaerobic bacteria species such as Salmonella, Bifidobacteria and 
Clostridia have been used for tumor treatment.  Most research on this area is focused on Salmonella 
and Clostridium, as reviewed below. 
2.3.1 Salmonella Mediated Cancer Therapy 
Salmonella is a gram negative facultative anaerobic bacterium that causes intestine infection. The early 
studies on Salmonella were focused on reducing its pathogenicity (septic shock).  In 1952, Graham and 
Coleman showed that Salmonella montevideo colonizes inside carcinoma tumors [10].  In order to use 
Salmonella as an anti-tumor agent, it must be made non-pathogen or, at least, its potential for harm 
must be attenuated.  
Early works on Salmonella were focused on making vaccines; as a side benefit, these works were 
also helpful for providing a bacterial strain that can be used as an anti-cancer agent. In 1951, Bacon et 
al. showed that Salmonella can be attenuated by auxotrophic mutations, such as those mutations that 
affect the biosynthesis of purines [11].  In 1981, Hoiseth and Stocker attenuated Salmonella  
typhlimurium by mutations that affect the biosynthesis of aromatic amino acids [12]. They also showed 
that the attenuated Salmonella can be used as a live vaccine.  
In 1997 researchers reported that attenuation increases the colonizing capability of Salmonella 
typhlimurium in tumors and that these attenuated strains can be used as gene delivery vectors. To 
explain the improved colonization, Pawelek et al. hypothesized that the necrotic part of tumors provides 
essential nutrients for auxotrophs [13].  They conducted their studies in animal models: melanoma-
bearing mice and mice implanted with human tumors such as human lung carcinoma A549, human 
colon carcinoma HCT 116, human breast carcinoma  BT20, human renal carcinoma CRL 1611, and 
human hepatoma HTB 52. They showed that attenuated Salmonella strains germinate in tumors 250- 
to 9000-fold higher than normal tissue, such as liver. They also engineered Salmonella to express genes, 
such as thymidine kinase from herpes simplex virus. Tumor growth regression was observed when the 
engineered Salmonella typhlimurium was injected into the tumor- bearing mice. 
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In 1999, Low et al. showed Salmonella retains its tumor-suppression properties when two genes from 
its chromosome are deleted. The deletion of the msbB gene reduces induction of TNFα (Tumor necrosis 
factor α), which in turn reduces the risk of septic shock. The deletion of the purI gene makes the bacteria 
dependent on an external source of adenine [14].  
In 2005, Ming Zhao et al. reported development of a genetically modified strain of S. typhlimurium.  
This strain, which is also known as S. typhlimurium A1, selectively grows in prostate tumors implanted 
in mice and causes tumor regression [15]. Normal tissue was cleared from S. typhlimurium A1 bacteria 
even in immuno-deficient mice. No side effects of the treatment were observed. S. typhlimurium A1 is 
auxotrophic (leucine-arginine dependent) and apparently receives sufficient nutritional support only 
from tumor tissue. When the bacteria were injected intravenously, they germinated inside PC-3 prostate 
tumors and caused tumor regression. 
In 2006, the same group reported on a further modification of S. typhlimurium A1, designed to 
increase its tumor targeting ability [16]. The strain was re-isolated after infection of a human colon 
tumor growing in mice. They injected the modified strain into the breast tumors in mice models.  This 
strain is known as S. typhlimurium A1-R and increases tumor targeting in vivo as well as in vitro 
compared to S. typhlimurium A1.  
Current research on Salmonella has focused on delivery and expression of therapeutic agents such as 
cytokines, prodrug-converting enzymes, and agents toxic to tumors.   
Even though attenuated Salmonella shows good tumor colonization and regression in animal models, 
the clinical results on human have been disappointing. Colonization of Salmonella in human patients 
is generally insufficient. Moreover the colonization of attenuated Salmonella in normal tissue, even 
transiently, causes side effects and reduces the specificity of this treatment as a gene transfer system 
[17]. 
2.3.2 Clostridium Mediated Cancer Therapy 
Clostridia are motile gram positive obligate anaerobic bacteria. Although some strains of Clostridia, 
such as C. botulinum or C. tetani,  are well known as pathogens, most  Clostridia  strains are non-
pathogenic. 
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In 1935 Connell used C. histolyticum to treat advanced cancers [18]. He concluded that the 
production of proteolytic enzymes in C. histolyticum causes tumor regression. In 1947, Parker et al. 
infected tumor-bearing mice by C. histolyticum to study tumor regression [19]. (This was the first study 
of tumor regression by bacteria). They observed considerable regression in a sarcoma tumor, indicating 
that Clostridium spores are good candidates to be used as anti-tumor agents.  
In 1955, Malmgren and Flanigan intravenously administered C. tetani spores into tumor-bearing and 
normal mice [20]. All tumor-bearing mice died within 48 hours because of the production of tetanus 
toxin in the tumor, but the non tumor-bearing mice survived without any tetanus symptoms.  The 
microscopic examination of the tumor and normal tissue sections indicated that the spores germinated 
exclusively within the tumor and released tetanus toxins, demonstrating specificity of colonization. 
In 1964, Möse and Möse intravenously injected C. butyricum M55 (later named C. oncolyticum, and 
now classified as C. sporogenes ATCC 13732) into mice with solid Ehrlich carcinomas [21]. The 
bacteria colonized the tumor; the necrotic part of the tumor was discharged as brownish liquid.  In the 
few mice that survived this deadly stage, tumor regrowth was observed from the remaining outer rim. 
These results were confirmed by other studies with other nonpathogenic spores of Clostridium and with 
different types of tumor models [22, 23].  (In 1967, Möse and Möse also showed that C. sporogenes is 
nonpathogenic by injecting this strain into themselves!) 
In 1967, Corey et al. reported on the treatment of five patients with neoplastic diseases by injection 
of 1010 spores of C. sporogenes. The patients developed only a mild fever during treatment [24]. 
However, to prevent patient mortality, surgery was required before completion of oncolysis: because 
of tumor regrowth from the viable outer rim, the clinical trial discontinued. These studies show that C. 
sporogenes can be safely used as a tumor-targeting agent. 
Combined treatments were explored in an attempt to destroy the tumor’s outer rim. For example, 
Clostridium administration was accompanied by chemotherapeutic agents such as 5-
Fluorodeoxyuridine and cyclophosphamide [23, 25]. Other combined treatments, such as Clostridium 
spores and local irradiation and high frequency hyperthermia showed significant results in mice-bearing 
melanomas [26]. In 1979, Möse administrated Clostridium spores to tumor-bearing rats while the 
oxygen level in the respiratory air of the animals was decreased to 11-12% [27]. These attempts were 
unable to resolve the issue of growth from the viable outer rim. 
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All these studies show that wild type Clostridium could colonize well inside the necrotic core of a 
tumor and destroy a significant portion of the tumor, but regrowth invariably occurs from the remaining 
outer rim.   
Over the last decade, a number of studies have addressed Clostridium based therapeutic approaches. 
Dang et al. screened anaerobic bacterial species such as bifidobacteria, lactobacilli and pathogenic 
clostridia for their tumor targeting capability. They reported that C. novyi had the best colonizing 
behaviour [28].  They removed a lethal toxin expressed by this strain and produced a non-toxic strain 
named C. novyi-NT. Intravenous administration of these bacteria into mice bearing Ehrlich ascites 
tumors resulted in tumor colonization and extensive oncolysis. They also showed that C. novyi-NT can 
efficiently infiltrate and extensively spread throughout the necrotic tumor regions. Similar to C. 
butyricum M55, germination of the spores led to enlargement of the necrotic regions and subsequent 
delays in tumor growth. The observations were tumor-type dependent; some colonization led to severe 
toxicity as a consequence of  so-called ‘tumor lysis’ syndrome. 
The authors of [29] used a Clostridium host as a tumor-specific gene delivery system. Because the 
required gene delivery systems were only applicable for saccharolytic strains, the initial experiments 
were undertaken with C. acetobutylicum and C. beijerinckii.  Unfortunately, these strains have been 
shown to exhibit suboptimal tumor colonization properties. Indeed, upon systemic administration of 
spores, colonization levels of the saccharolytic C. acetobutylicum and C. beijerinckii are 1000-fold 
lower compared to proteolytic C. sporogenes strains [30]. Despite their weak tumor colonization 
properties, the use of saccharolytic strains (as opposed to a proteolytic host) may be beneficial when 
the introduction of the desired therapeutic gene is required. The use of a proteolytic host may cause 
increased degradation of extracellular therapeutic protein [31].  
There have been efforts on genetic manipulation of strains with good colonization properties, such 
as C. sporogenes. In 2002, Liu et al. described an electroporation protocol for transformation of C. 
sporogenes [32].  They injected engineered C. sporogenes accompanied by 5-fluorocytosine (5-FC) 
prodrug administration into tumor bearing mice. The C. sporogenes strain was genetically engineered 
to express E. coli cytosine deaminase, which converts prodrug 5-FC to fluorouracil, an anticancer drug 
(Figure 2). Unfortunately, their experiments were not repeatable. In 2006, Theys et al. developed a 
conjugation-based gene transfer protocol that allows the construction of recombinant C. sporogenes 
strains [4]. They genetically engineered C. sporogenes to produce Nitrogen reductase (NTR), which 
converts prodrug CB1954 (5-aziridinyl-2, 4-dinitrobenzamide) to its 10000-fold more toxic 4-
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hydroxylamine (4HX) derivative, which can act as an apoptosis agent (Figure 2). As a result of these 
efforts, it is now possible to design gene therapies using the strain with the highest tumor colonization 
(i.e. C. sporogenes). Not surprisingly, preclinical experiments with recombinant C. sporogenes have 
shown increased anti-tumor efficacy in comparison with C. acetobutylicum or C. beijerinckii [33]. 
 
Figure 2: CD and NTR convert prodrug to drugs which are highly toxic [33] 
 
Besides Clostridium, other anaerobic bacteria species such as Bifidobacterium can be used to deliver 
genes to tumors [34]. However, the rather low colonization efficiency and the tendency to clump, rather 
than distribute within necrotic areas, appeared to make Bifidobacteria inferior to the optimal strain of 
Clostridia. However Bifidobacteria exhibit inefficient colonization  of tumors, in comparison with 
Clostidia. Moreover, Bifidobacteria  colonies forms clumps,  preventing fast and even distribution in 
tumors. 
2.4 The Effect of Oxygen on the Growth of Clostridium 
This section describes the reasons for growth inhibition of Clostridium in the oxygenated parts of a 
tumor. The study of oxygen metabolism in anaerobic bacteria suggests ways in which these bacteria 
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may be made oxygen-tolerant, which could allow them to colonize to the outer rim of a tumor, leading 
to complete oncolysis.  
2.4.1 Facultative and obligate anaerobic Clostridia species  
Clostridia, Sporolactobacillus and Amphibacillus are all spore forming gram positive bacteria. They 
all lack Krebs cycle enzymes and the enzyme catalase, which catalyzes the degradation of hydrogen 
peroxide.  Sporolactobacillus and Amphibacillus are facultative anaeorobes; they can grow well in the 
presence of oxygen. In contrast, Clostridia are known obligate anaerobes; they cannot grow in the 
presence of oxygen. A number of reasons for this growth inhibition have been proposed. One of the 
major hypotheses is that Clostridium does not have a mechanism to eliminate oxygen derivatives, such 
as hydrogen peroxide (H2O2), superoxide and hydroxyl radicals [35].  Strong evidence for this 
hypothesis is that almost all Clostridium species lack catalase, which catalyzes the degradation of 
hydrogen peroxide [36]. An alternative hypothesis relates to the reduction in energy production when 
anaerobic bacteria are exposed to oxygen [37], as follows. Normally, NAD(P)H oxidases are fully 
engaged in the energy production system of anaerobic bacteria. When these cells are exposed to oxygen, 
NAD(P)H oxidases are used to eliminate oxygen. Therefore, energy production in the cell is reduced. 
The reason that the growth rate of Amphibacillus is unaffected by presence of oxygen is related to their 
ability to eliminate oxygen derivatives by NADH oxidase [38], [39]. For example, in Amphibacillus 
xylanus, NADH oxydase can act as a peroxidase, with the final product of oxidation being water [40-
42].   
Research on the effect of oxygen on Clostridium butyricum has revealed that this strain is able to 
consume oxygen. C. butyricum stops growing in the presence of O2, but when the oxygen has been 
consumed it grows normally [35]. This finding shows that oxygen does not damage the enzymes 
involved in the bacteria’s metabolism. It can be concluded that suspension of growth is a means of 
survival for this Clostridia species. The conclusion is that the production of water-forming NADH 
oxidase can make an anaerobic bacteria aerotolerant, with the degree of aerotolerancy dependent on the 
abundance of the NADH oxidase. 
2.4.2 Oxygen Metabolism in Anaerobes 
In 2005, Kawazaki et al. hypothesized that Clostridia have a metabolic pathway to eliminate oxygen 
radicals. In Clostridium aminovalericum a NADH oxidase gene is characterized named noxA. The final 
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product of this oxidase is H2O. When the bacteria are exposed to oxygen, the expression of the noxA 
gene strongly increases, indicating that this gene is involved in oxygen metabolism [43]. 
To identify the genes responsible for eliminating oxygen radicals in C. acetobutylicum, Kawazaki et 
al. searched the genome of C. acetobutylicum for genes homologous to noxA. The identified genes are 
listed in Table 1.  
The nror gene expresses a protein homologue to an NADPH oxidase [44].  NROR does not function 
as an NADH oxidase. Western blot analysis showed that the nror, fprA2 and dsr genes were transcribed 
by a single promoter and expressed a protein homologue to flavoproteins, which are involved in 
removal of oxygen radicals. These genes were upregulated after 10 minutes of exposure to 5% O2. The 
gene dsr is also expressed by a separate promoter, which was upregulated after 30 minutes of oxygen 
exposure[43]. 
 
 
 
 
Figure 3: Gene cluster downstream of nror gene [43] 
Table 1: Genes involved in oxygen metabolism of C. acetobutylicum[43] 
Gene identification Gene name Primer sequence (5’–3’) 
CAC2448 nror  F,AGATGATTTATATGAAAAGCAC 
R,AATGTATTTATCTTCTTGTGCAC2449 
CAC2449 fprA2  F, AGTTCTAAATCCTAGTCTCC 
R, CTCAGATGGAACAAATAAAC 
CAC2450, dsr  F, ATGAATAACGATTTATCAATTTAC 
R, TTATATATCTGCTTTCCATAGG 
 
CAC2451,  orf2451  F, GAGCTTAATATAATAGTTCC 
R, ACATTTATTTAATAGCAGCC 
CAC2452,  
 
fld1  F, GTCGAGGAGGAATTATTATG 
R, TCTTCCTTACTAGGTGCCTC 
 
1203bp 1140bp 
nror Fld1 fprA2 Orf24dsr 
378bp 1041bp 426bp 
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The gene fprA2 expresses a protein homologue to an oxygen-induced flavoprotein that was already 
identified by Kawasaki et al [45].  C. acetobutylicum’s Dsr protein functions as a superoxide reductase 
(SOR) and produces H2O as final product. Kawazaki et al. concluded that the proteins encoded by the 
nror operon may form an enzyme complex (Nror-FprA2-Dsr) that functions as a radical oxygen species 
(ROS) scavenger in oxygen metabolism of  C. acetobutylicum.  
 
Two other genes located downstream of dsr are orf2451 and fld1 (Figure 3). The gene fld1 codes for 
a flavodoxin homologue; orf2451 codes for a methyltransferase-similar protein that is involved in stress 
response to heavy metals, drugs and oxygen. The expression of these two genes is also highly 
upregulated 10 minutes after exposure to 5% oxygen.  
Kawazaki et al. also found genes transcribing rubrerytherins (ruby, rub), which are O2 induced 
proteins. These genes are upregulated when the bacteria are exposed to low levels of oxygen. These 
proteins function as superoxide dismutases.  The authors identified many genes in C. acetobutylicum 
that are upregulated after aeration and that encode peroxidase like proteins.   They also showed that the 
activity of NAD(P)H-dependent (hydrogen) peroxide reductase increases after exposing C. 
acetobutylicum   to 5% oxygen  [43]. 
These results verify the existence of oxygen metabolism and show the importance of active oxygen 
and lipid peroxide scavenging enzymes for the growth of C. acetobutylicum in the presence of oxygen. 
In 2006, Kawazaki et al. investigated the effects of oxygen levels on the growth of Bifidobacterium, 
which is a gram positive anaerobic bacterium. Oxygen sensitive Bifidobacterium accumulates hydrogen 
peroxide (H2O2) in the presence of O2, inhibiting  growth. In the presence of oxygen, the O2 sensitive 
Bifidobacterium cells recovered their growth rate when the experimenters added catalase to the 
medium; no accumulation of peroxide was observed in species that tolerate oxygen up to 20%. No 
significant changes in fermentation were observed, showing that oxygen did not damage the 
metabolism of the bacteria  [46].  
The existence of oxygen metabolism in anaerobes strengthened our hypothesis that Clostridium can 
be made aerotolerant by the introduction of a synthetic oxygen metabolism pathway. This synthetic 
metabolism should be able to scavenge radical oxygen species and produce water as the final product. 
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2.4.3 noxA Gene from C. aminovalericum is a Good Candidate to be Engineered in 
Clostridium 
In [47] a range of oxidase and related enzymatic activities were observed in Clostridium strains. 
NADH/NADPH oxidase, NADH/NADPH peroxide and super oxide dismutase (SOD) activities were 
observed in the cytoplasmic fraction of nine strains of Clostridia (Table 2). No catalase, fatty acid 
peroxidase, cytochrome peroxidase, idide peroxidase, ascorbate peroxidase, glutathione peroxides or 
chloroperoxidase activities were detected in Clostridium strains [42].  The production of NADH 
oxidase in C. sporogenes, which is the most anaerobic strain, is much lower than that of C. 
aminuvalericum, which is the most aerotolerant species. (Clostridium aminovalericum can grow in low 
levels of oxygen (3%O2/97%N2).  
 
Table 2: Oxidase and active oxygen-scavenging enzyme activities [47] 
 Oxidase activities(O2 nmol/min/mg protein) Enzyme activity mU/mg protein 
 NADH Oxidase  
NADPH 
oxidase 
 
Pyrovate 
Oxidase 
 
Glucose 
Oxidase 
 
NADH 
Peroxidase 
 
NADPH 
peoxidase 
 
SOD 
(U/mg) 
 H2O 
producer 
H2O2  
Producer  
C. butyricum 
 
43.4 123 6.0 0 0 5.0 5.8 1.37 
C. scatologenes 
 
24.0 40.0 44.6 0 0 35.3 71.1 1.75 
C. sporogenes 7.8 16.6 3.5 0 0 11.8 10.2 0.75 
C. oceanicurn 
 
40.0 61.4 10.9 0 0 10.0 4.3 0.61 
C. bifermentans 7.8 28.0 1.1 5.1 0 6.1 2.5 1.26 
C. mangenotii 15.0 106.6 2.7 15.3 0 12.0 8.6 2.60 
C. barkeri 40.0 71.0 123.0 0 0 40.0 36.3 0.69 
C. innocuum 17.1 252.7 1.1 0 0 27.7 7.8 1.05 
C. 
aminovalericum 
78.0 82.9 12.8 0 0 27.0 17.7 ND 
 
Because C. sporogenes does not have a system to scavenge hydrogen peroxide, the engineered 
NADH oxydase should be a water forming type.  The production of hydrogen peroxide as the final 
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product may inhibit the bacteria growth, therefore noxA gene from C. aminovalericum seems to be the 
best candidate. 
2.5 Quorum Sensing Mechanisms in Bacteria 
Constitutive expression of noxA gene could make C. sporogenes sufficiently aerotolerant that it would 
lose its tumor-targeting property and colonize healthy oxygenated tissue. Therefore the production of 
noxA gene in a therapeutic strain should be tightly controlled.  We propose control by a genetic circuit. 
The genetic circuit should not express noxA before the complete colonization of C. sporogenes in the 
necrotic core of the tumor. When the bacterial concentration in the tumor becomes large enough, the 
genetic circuit will trigger the expression of the noxA gene, thus making the C. sporogenes cells 
aerotolerant. These aerotolerant cells can then invade the outer rim of the tumor. To ensure that the 
aerotolerant phenotype is exhibited only in the tumor, the genetic circuit should generate a strict switch-
like (on/off) behavior. Bacterial quorum sensing mechanisms are good candidates for this design. 
Quorum sensing involves control of gene expression by local cell population density, as we review 
next. 
 
Just as the cells of higher organism communicate with one another using hormones, bacteria 
communicate using small hormone-like molecules called autoinducers. This communication allows 
bacteria to sense their local population density. Bacteria can respond to their population concentration 
and synchronize their activities by controlling gene expression when a ‘quorum’ has been reached.  
 
Quorum sensing mechanisms play important roles in a range of bacterial functions. For example, 
some bacteria, such as Pseudomonas aeruginosa, use this mechanism to produce biofilm [48], some, 
such as Serrati liquefaciens [49] and Erwinia chrysanthemi [50], use quorum sensing to regulate 
virulence factors and some, such as vibrio harveyi and vibrio fischeri, use it to control the production 
of luminescence [51]. Almost all bacteria use quorum sensing mechanisms to regulate gene expression 
[52]. There are some similarities and differences between the quorum sensing mechanisms evolved in 
different bacteria. All quorum sensing mechanisms are based on a positive feedback which results in a 
switch-like behavior. The cell density in all bacteria is measured by an autoinducer whose concentration 
represents the cell population. The autoinducer fires a cascade of events that results in gene expression. 
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This circuit switches on when the autoinducer concentration reaches a threshold. In gram negative 
bacteria, the autoinducer freely diffuses through the cell membrane, while in gram positive bacteria, a 
receptor actively exports autoinducer to the extracellular space.  In gram positive bacteria, the 
autoinducer fires the genetic circuit by auto-phosphorylation of a histidine kinase membrane binding 
receptor. But in gram negative bacteria the complex of autoinducer with a cytoplasmic receptor 
activates gene transcription. 
2.5.1 Quorum Sensing Mechanism in Gram Negative Bacteria 
Quorum sensing was first observed in Vibrio fischeri, which is a gram negative rod-shaped marine 
bacteria [53]. It can be found in seawater at a concentration of 10 cells per ml. Vibrio fischeri can  
also grow symbiotically in specialized light organs of the Hawaiian squid Euprymna scolopes at a 
concentration around 1010 cells per ml. When the population of bacteria reaches this threshold, a 
genetic circuit is fired inside the bacteria that results in the production of bioluminescence. The squid 
uses this light to mask its shadow and hide from its predators, and the bacteria use the squid as a 
source of nutrition [51].     
 
 
 
 
 
 
 
 
 
 
Figure 4: Lux Quorum sensing mechanism in Vibrio fischeri  
 
Figure 4 shows the lux quorum sensing circuit of Vibrio fischeri. Proteins LuxR and LuxI control 
production of the luciferase genes (luxICDABE) that produce light. LuxI is an autoinducer synthase that 
 
luxIluxR
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LuxR
luxC luxD luxA luxB luxE
LuxI
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  17 
catalyzes the production of acyl-homoseine lactone (AHL), 3OC6-homoserine lactone, from S-
adenosylmethionine (SAM) and acyl-acyl carrier protein (acyl-ACP) , which are generated via fatty 
acid biosynthesis pathways [54].  AHL converts SAM and Acyl-ACP into three components: 3OC6-
homoserine lactone, 5′-methylthioadenosine and apo-ACP [55]. Figure 5 shows schematically the 
synthesis of AHL by LuxI. 
 
 
 
 
 
 
: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AHL can diffuse freely across the cell membrane. Therefore the extracellular concentration of AHL 
increases as the local population increases. When the AHL concentration reaches a threshold, LuxR 
binds to AHL and the LuxR-AHL dimer acts as a transcriptional activator for the lux promoter. The lux 
promoter (plux) expresses the luciferase genes (luxICDABE) along with luxR and luxI.  The expression 
of the luxI gene by plux results in a positive feedback. This positive feedback is the core of the quorum 
SAM 
SAM 
SAM 
acyl-ACP 
ACP 
acyl-SAM 
AHL 
5′-methylthioadenosine 
 
5′-methylthioadenosine 
 
LuxI 
LuxI 
LuxI 
LuxI 
LuxI 
acyl-ACP 
Figure 5: synthesis of Acyl-HSL by LuxI 
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sensing mechanism. Since the AHL concentration is a representative of the cell population, the bacteria 
can sense its population and adjust gene expression accordingly.  All gram negative bacteria have 
similar quorum sensing mechanism elements analogous to LuxI , LuxR and AHL. The AHLs differ in 
among the gram negative bacteria, with varying acyl chain length. 
2.5.2 Quorum Sensing Mechanism in Gram Positive Bacteria 
Gram positive bacteria use oligopeptides of 10 to 20 amino acids as autoinducer signals to communicate 
with each other.  Receptor proteins activate transcriptional activators by phosphorylation (and thus play 
a role analogous to LuxI and LuxR in V. fischeri). The transport of autoinducer across the cell 
membrane is an active process [56] (which is a key difference with the gram-negative mechanism). 
 An example of quorum sensing in gram positive bacteria is provided by Staphylococcus aureus. S. 
aureus infections are benign at low cell density, but become a deadly at high density.  At low density 
the bacteria expresses proteins that enhance its attachment to the human body. At high density it 
represses this circuit and start expression of toxins and protease. Figure 6 shows the quorum sensing 
mechanism of Staphylococcus aureus.   
Protein AgrD produces a peptide autoinducer (AIP). AgrB is a receptor that exports AIP to the 
extracellular space and adds a thiolactone ring to it. The modified AIP binds to another receptor called 
AgrC. AIP mediates the auto-phosphorylation of AgrC. Active AgrC mediates the phosphorylation of 
ArgA. Phospho-ArgA acts as a transcriptional activator for agrB, agrD, agrC, AgrA and RNAIII genes 
by activating expression from the P2 and P3 promoters. RNAIII represses the expression of adhesion 
factors and induces the expression of toxins and secreted factors. The activation of the agr promoter by 
phospho-ArgA results in a positive feedback which switches on the gene expression when the cell 
population reaches a threshold [57]. Recently the crystal structure of AgrA has been shown to have a 
binding site for small molecules that inhibit AgrA from binding to DNA [58] 
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2.6 Mathematical Modeling of Quorum Sensing mechanisms in gram negative 
and gram positive bacteria 
Quorum sensing systems involve networks of components interacting through a range of feedback 
connections.  Consequently, mathematical models may be called for to interpret their behaviour.  A 
complete model analysis will be presented in chapter 3.  Here, we review the relevant system analysis 
in the literature.  
Goryachev and Lee [59] performed a computational system analysis on the quorum sensing 
mechanism of Vibrio fischeri, based on a differential equations model.  They considered three different 
layouts for analysis: a minimal QS network, a basal QS network and a basal QS network with 
dimerization. In the minimal QS network they ignored the auto regulation of the LuxR protein by 
assuming constitutive expression of the luxR gene. In the basal QS system they considered both the 
luxR and luxI positive feedback loops but ignored dimerization of the LuxR protein.  In the third model 
they considered the effect of dimerization on the system behaviour.  The standard chemical kinetic 
Inside 
Outside 
Secreted Factor 
Cell adhesion protein 
AgrD 
AgrA~P AgrA 
P2 P3 
agrB RNAIII agrD agrA agrC 
AIP 
AgrC 
AgrB 
Figure 6: Quorum sensing in Staphylococcus aureus [53] 
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approach was used to model the biochemical interactions. Their analysis of these three system reveals 
that dimerization is important; it improves the stability of the off state and reduces the noise.  They 
concluded that both the luxR positive feedback loop and the dimerization are important for the switch-
like behaviour of the system. 
Williams et al. [60] used a combination of experiments and modeling to validate the existence of 
LuxR autoregulation and highlight the effect of this positive feedback loop on the switch-like behaviour 
of the V. fischeri quorum sensing mechanism. They replaced the lux genes downstream of the lux 
promoter (i.e. luxIABCD) with a green fluorescent gene (gfp) and constructed a circuit termed lux01.  
This Lux01 circuit was cloned into E. coli.  They measured the gfp intensity in different autoinducer 
concentrations and drew null clines.  Measurements of the gfp signal under dilutions of autoinducer 
revealed that the system exhibits hysteresis.  They also measured the LuxR concentration while varying 
the autoinducer concentration and showed that at a threshold concentration of autoinducer, the LuxR 
abundance increases rapidly. This confirms the switch-like response of LuxR, due to the positive 
feedback in the autoregulatory loop. They developed a mathematical model to further investigate this 
feedback loop. Their model shows bistability if and only if they include LuxR autoregulation.  
Kutter and Hence [61] considered a more comprehensive model of the V. fischeri quorum sensing 
system, which includes the interplay of the lux and ain systems, a second quorum sensing mechanism 
involving  in bioluminescent regulation in V. fischeri.  The ain system is regulated by an autoinducer 
known as C8HSL and a transcription activator called LitR, They assumed that LitR is the only 
transcription activator of the luxR gene.  They ignored the LuxR auto regulation.  They showed that 
their model validates the experimental results of mutants of two different Vibrio fischeri strains (ES114 
and MJ1). They also showed that their model exhibits bistability.  
Some system analysis of quorum sensing mechanisms of gram positive has also been carried out.  
Gustafsson et al. [62] developed a mathematical model for the quorum sensing system in 
Staphylococcos aureus, as shown in figure 6 in Section 2.5.2. Mass action principals and fundamental 
kinetic principals were used to model the interaction between AIP and AgrC, the phosphorylation of 
AgrA, and expression of the agrA, agrC and RNAIII genes. By plotting the RNAIII concentration 
against the AIP concentration, they showed that the system exhibits switch-like behaviour and 
hysteresis. The protein SarA is known to increase the basal expression of AgrA. The experimental 
results show that SarA mutants have the same final level of RNAIII, but are induced at a higher 
concentration of AIP, meaning that decreasing the basal level of AgrA should increase the threshold 
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concentration but have no effect on the final concentration of RNAIII. Simulation of the mathematical 
model validate this experimental observation. Gustafsson et al. also studied the effect of inhibitory AIP 
(from other strains), which decreases the threshold concentration. They concluded that a slight increase 
in the affinity of AgrC for AIP will reduce considerably the threshold inhibitor concentration required 
to turn the system off [62]. 
Karlsson et al. [63] studied the quorum sensing system that regulates competence in Staphylococcos 
pneumonia. Experimental results show that competence is down-regulated a short time after induction. 
They hypothesised that the down-regulation of competence is due to expression of an inhibitor of the 
quorum sensing promoter. To study their hypothesis, they developed a mathematical model for the 
competence quorum sensing system. They plotted the steady state concentration of the transcriptional 
activator as a function of extracellular concentration of competence stimulation peptide. Their plot 
shows hysteresis and verifies that the system exhibits bistability. They conducted a sensitivity analysis 
to identify which parameters are significant in the competence shut down response. This analysis 
showed that the synthesis of all genes products are important, confirming that a repressor is down 
regulating all genes at the transcriptional level [63].    
Jabbari et al. [64] developed a more comprehensive model for the Staphylococcos aureus quorum 
sensing mechanism. They included the dynamics of AIP production and simulated the whole quorum 
sensing genetic circuit, including the intra- and extracellular production of AIP and proteins. They 
developed a dimensionless mathematical model using the initial concentration of a range of proteins 
and mRNAs. Simulation of their model shows hysteresis and bistability. They used the dimensionless 
model to explain how the switch-like response in virulence production occurs.    
2.7 Synthetic Biology 
In this project, a synthetic biology approach is proposed for engineering a quorum sensing system into 
Clostridia. Here, we briefly review some of the relevant literature on synthetic biology. 
The term  “synthetic biology” was used by Barbara Hobom in 1980  to explain  recombinant DNA 
for engineered bacteria . It was used again in 2000 by Eric Kool to describe the synthesis of unnatural 
molecules in living systems [66].  During the last decade, researchers have used the term “synthetic 
biology” to describe the application of an engineering approach into biology, with the goal of designing 
and constructing new or modified living system with new functions. 
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Through Synthetic Biology, engineers are treating biology as the physics and chemistry of a new 
century.  They are drawing analogies between proteins and genes and transistors, diodes and resistors. 
These elements are assembled together to produce genetic or protein devices, similar to logic gates and 
switches in digital computers. Furthermore these biological gates and switches are connected in such a 
way to manipulate the genetic and metabolic pathways that are the integrated circuits of biological 
systems. Finally using these pathways, biological systems can be redesigned to produce new synthetic 
organisms with novel functions that do not exist in nature [66].  
 
In the engineering approach, an engineer follows standard steps: designing, modeling, implementing, 
testing and validating to construct a novel system, using tools such as a standardized library, computer 
aided design (CAD), computer aided engineering (CAE) and computer aided manufacture (CAM) 
software. The designer may go back and forth between different steps to optimize the design. To apply 
this approach to biology, researchers in synthetic biology are developing standardized libraries such as 
BioBrick and BglBrick [67],[68], CAD and CAE software such as Clottho Framework and Eugene 
language [69][70] and ultimately DNA synthesis machines which plays the role of CAM software and 
CNC in synthetic biology [71][72].   Although following the route of mature engineering disciplines 
seems promising, the complexity of biological systems and the context-based behavior of biological 
parts may makes the route longer than for other engineering fields.   
2.7.1 Implications of Quorum sensing in synthetic biology 
The elements of bacterial quorum sensing mechanisms have been used widely in synthetic biology. 
Weiss and Knight [73] used the Vibrio fischeri quorum sensing mechanism to develop controlled sender 
and receiver populations in E. Coli.   You et al. [74] developed a programed population control circuit 
by putting a killer gene under the control of the lux promoter. They developed a biological feedback 
circuit to control a cell population.  Basu et al. [75] produced a pulse generator using receiver and 
sender devices by putting the luxI gene under the control of the tetracycline promoter (ptetR) in their 
sender device and, in the receiver device, GFP and CI repressor gene of lambda phage under the control 
of lux promoter. They spatially controlled the production of GFP: the receiver bacteria near and far 
from the sender bacteria did not produce GFP, while the intermediate range cells did. This was the first 
step toward bacteria pattern formation. Basu et al. [76] reported programmed pattern formation using 
  23 
the same sender device and similar genetic circuit. They constructed a low-detect plasmid and three 
high-detect plasmids harboring three different luxR genes with three different sensitivity to AHL 
concentration. They developed their band detector device by combining the low detect plasmid with 
each of the high detect plasmids. Putting sender strains in different parts of a petri dish, they formed a 
variety of patterns such as an elipse, a heart and a clover. 
The elements of quorum sensing mechanisms were used to develop synthetic inter- and intra-species 
ecosystems. Ballagade et al. [77] developed a synthetic predator-prey E.coli ecosystem using elements 
of Vibrio fischeri and Pseudomonas aeruginosa quorum sensing mechanisms.  In their system, a killer 
gene is expressed by a constitutive promoter in the predator strain, while a density-dependent promoter 
(plux) is incorporated into the prey. An antidote gene is expressed by a lux promoter in the predator, 
which inhibits the expression of killer gene in high density. The killer gene is expressed by a density 
dependent promoter (plux) in the prey, thus killing prey at high density. At low prey density the predator 
will be killed due to the constitutive expression of killer protein in Predator. Prey will grow until they 
reach a threshold level of  AHL production, thus activating the lux promoter in the predator and the 
prey resulting in production of antidote protein in the predator and killing protein in prey. The 
production of antidote rescues the predator while the production of killing protein kills the prey. This 
will result a predator-prey ecosystem.   
2.7.2 Application of synthetic biology in bacteria mediated cancer therapy 
A number of projects have addressed the engineering of Salmonella and E. coli to be used as anti-
tumor devices.  Anderson et al. engineered E. coli to express the invasin gene (inv) from Yersinia 
pseudotuburculosis to invade cancer cells. They developed cell concentration-dependent, hypoxic and  
arabinose dependent strains by cloning the inv gene downstream of lux promoters, hypoxia-responsive 
fdhF promoter and  the arabinose-inducible araBAD promoter respectively.  
Royo et al [79] engineered some elements of the naphthalene degradative pathway, which is 
regulated by acetyl salicylic acid (ASA), from Pseudomonas putida into Salmonella enterica. ASA is 
an anti-inﬂammatory drug. In this pathway the NahR protein is a transcription factor for the Psal 
promoter which in turn activates expression of XylS2. Both NahR and XylS2 are activated by ASA. 
The activated XylS2 in turn activates the Pm promoter, which expresses the target gene cytosine 
deaminase. Cytosine deaminse converts prodrug 5-FC to fluorouracil, an anticancer drug 
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Xiang et al. [80] engineered E. coli to express the short hairpin RNA (shRNA) invasin gene (inv)  
and two other genes that are necessary for transforming shRNA  into mammalian cells. shRNA  cleaves 
the mRNA of a cancer gene termed CTNNB1.  In most colon cancers, CTNNB1 is overexpressed or 
mutated. Oral or intravenous administration of E. coli into tumor-bearing mice resulted in shRNA  
production in the tumor, which silenced the CTNNB1 gene at both the mRNA and translation level.  
 
Prindle et al. [81] translated some synthetic genetic circuits already constructed and tested in E. coli, 
such as fast, robust and tunable genetic oscillator,  genetic clocks and toggle switch, into Salmonella 
thyphimurium. All of these devices can be used to regulate the dose and duration of drug production in 
a tumor. 
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Chapter 3 
Mathematical Modeling and analysis of the Quorum Sensing 
Mechanism 
3.1 Introduction 
Mathematical modeling is a powerful tool for exploring the dynamic behaviour of a system. From an 
engineering perspective, it can also be used to guide the modification of a system to produce desired 
behaviour. This model-based design approach is common in traditional engineering fields, and is also 
applicable to engineering of biological systems [65]. The chapter contains an analysis of mathematical 
models of quorum sensing mechanisms in gram negative and gram positive bacteria. Analysis of these 
models demonstrates the effect of variation in network modules and parameters on the system 
behaviour, and so highlights key design parameters for engineering of these systems.  
As discussed in chapters 5 and 6, we explored the possibility of using either gram-negative or a gram-
positive quorum sensing mechanism for controlling gene expression in C. Sporogenes. Although the 
implementation of a gram negative system into C. Sporogenes was not successful (Chapter 6), the 
analysis of this system may still prove useful in alternative implementations, or in improving our 
understanding of quorum sensing mechanisms in general. 
This project investigates the use of quorum sensing to control the aerotolerance of bacteria that have 
been targeted to solid tumors. Two key performance measures of such a system are (i) the threshold 
bacterial concentration at which expression of the aerotolerance enzyme is triggered and (ii) the 
resulting steady-state enzyme concentration.  To achieve optimum regression, these values will need to 
be adjusted depending on tumor size. Analysis of a mathematical model can reveal which design 
parameters have the most significant impact on these performance measures, and how these parameters 
should be chosen to arrive at optimum performance. 
From a control engineering perspective, we are developing a feedback control system to regulate the 
production of aerotolerance enzyme in response to the local density of the bacterial population.  In the 
quorum sensing system, the autoinducer acts as a sensor (sensing the cell population) and sends a signal 
to the controller, which is the transcription and translation mechanism of the bacteria. Although we are 
unable to separate this control system into a “plant” and “controller” (as in traditional feedback control 
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design), we can nevertheless aim to tune the gains of the controller to achieve desired behaviour. The 
sensitivity analysis presented in this chapter indicates how, in both gram positive and gram negative 
quorum sensing systems, the behaviour of the controlled system can be tuned by changing the gains of 
the controller.   
3.2.1 Modelling a Gram Negative Quorum Sensing Mechanism  
As discussed in Section 2.5.1, the quorum sensing mechanism of Vibrio fischeri is a prototype of gram 
negative quorum sensing systems. As shown in the network in Figure 4, on page 16, in this system, the 
production of bioluminescence results from the quorum sensing loops, with autoinducer 3-oxo-C6. 
Engineered instances of this system confirm that the Lux loop is sufficient to generate switch-like 
quorum-sensing behaviour in non-native bacteria [59].  
As reviewed in Section 2.6, a number of kinetic models of quorum sensing mechanisms have 
appeared in the literature. We focus on the model of Goryachev and Lee [59], which describes the lux 
quorum-sensing loop in Vibrio species.  
 
Figure 7: The quorum sensing layout of V. Fischeri used by Goryachev and Lee [59], Ae: 
extracellular AHL, Ae: intercellular AHL, I:LuxI, R:LuxI, P= LuxR-AHL, D:LuxR-AHL dimer,  
S: S-adenosylmethionine (SAM), Im: LuxI mRNA, Rm: LuxR mRNA 
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As shown in Figure 7, the authors focused on the two positive feedback loops involving luxI and 
luxR, while neglecting the effects of the ain and the LuxQ/P loops, as well as the effect of C8 
competition with AHL on binding with LuxR protein.  Their analysis reveals that the LuxR positive 
feedback loop and LuxR dimerization are significant contributors to the bistability of the system.   
We next review the kinetic formulation of the Goryachev and Lee model [59]. The formation of the 
LuxR-AHL complex is described by the following reaction 
                                                  𝐴 + 𝑅
𝑘1
⇌
𝑘−1
𝑃                                                        (1) 
where A,R and P are  AHL, LuxR and LuxR-AHL respectively, and 𝑘1 and 𝑘−1 are the rates of 
association and dissociation.  
Dimerization of the LuxR-AHL complex (P) is described as: 
                                                           2𝑃
𝑘2
⇌
𝑘−2
𝐷                                                                           (2) 
where 𝑘2 is the association rate and 𝑘−2 is the dissociation rate, and D is the dimer.   
 
These reactions occur quickly on the time-scale of gene expression processes, so we can consider a 
rapid equilibrium assumption for P and D. Defining 𝐾1 as the ratio of the association rate 𝑘1 to the 
dissociation rate 𝑘−1, the concentration of P is given by:  
                                                  𝑃 =
𝑘1
𝑘−1
𝐴𝑅 = 𝐾1𝐴𝑅                                        (5) 
A rapid equilibrium assumption for the formation of D, and substituting for P from Equation (5) 
yields: 
                                           𝐷 =
𝑘2
𝑘−2
𝐾1
2𝐴2𝑅2 = 𝐾2𝐾1
2𝐴2𝑅2                                       (6) 
where 𝐾2 is the ratio of association to the rate of dissociation of the dimer. 
 
The mRNA dynamics for LuxR (Rm) and LuxI (Im) can be described by:   
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{
 
 
𝑑𝑅𝑚
𝑑𝑡
= 𝑘5 +
𝐾3𝐷
𝐾4+𝐷
− 𝑘6𝑅𝑚 
𝑑𝐼𝑚
𝑑𝑡
= 𝑘9 +
𝐾7𝐷
𝐾8+𝐷
− 𝑘10𝐼𝑚 
                                                                     
(9)
(10)
 
where 𝑘5 and 𝑘9 are basal transcription rates for 𝑅𝑚 and 𝐼𝑚, respectively, 𝐾3  and 𝐾7  are the maximal 
rates for activated transcription, 𝐾4 and 𝐾8 are dissociation constants for D-promoter binding and 𝑘6 
and 𝑘10 are the corresponding mRNA degradation rates.  Considering that mRNA dynamics are much 
faster than protein dynamics, a quasi-steady-state assumption for the mRNA concentration gives the 
following equations for Rm an Im   
                                        
{
 
 𝑅𝑚 =
1
𝑘6
(𝑘5 +
𝐾3𝐷
𝐾4+𝐷
) 
𝐼𝑚 =
1
𝑘10
(𝑘9 +
𝐾7𝐷
𝐾8+𝐷
) 
                                                                                
(11)
(12)
 
The concentrations of proteins LuxR (R) and LuxI (I) are described by  
                                            {
𝑑𝑅
𝑑𝑡
= 𝑘11𝑅𝑚 − 𝑘12𝑅 
𝑑𝐼
𝑑𝑡
= 𝑘13𝐼𝑚 − 𝑘14𝐼 
                                                                                     
(13)
(14)
 
where   𝑘12 and   𝑘14  are the corresponding degradation rates, and 𝑘11  and  𝑘13 are per-mRNA 
translation rates.              
Substituting equations (11) and (12) into equations (13) and (14) yields: 
                                                  
𝑑𝑅
𝑑𝑡
=
𝑘11
𝑘6
(𝑘5 +
𝐾3𝐷
𝐾4+𝐷
)  − 𝑘12𝑅                 (15) 
                                                  
𝑑𝐼
𝑑𝑡
=
𝑘13
𝑘10
(𝑘9 +
𝐾7𝐷
𝐾8+𝐷
) − 𝑘14𝐼                (16) 
To address the dynamics of AHL (concentration A) , the following assumptions are made: (i) the 
production rate of AHL depends only on the abundance of LuxI (i.e. the substrate concentration is 
steady), and (ii) the rate of diffusion of AHL into the cell is proportional to the difference between the 
extracellular and intracellular concentrations of AHL. Thus 
                                                     
𝑑𝐴
𝑑𝑡
= 𝑘15𝐼 + 𝑘16(𝐴𝑒 − 𝐴)                                (17) 
where 𝑘15 is the per-LuxI production rate, 𝐴𝑒 is the extracellular AHL concentration, and 𝑘16 is the 
diffusion rate.  
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We could now apply equation (6) to write D in terms of A and R to arrive at a model consisting of 
three differential equations. However, the authors further reduce the description of the dynamics by 
applying a quasi-steady-state assumption to LuxI ,which is translated from a short mRNA compared to 
LuxR. Substituting the quasi steady state for I (from Equation (9)) into equation (17) yields:  
                                                  
𝑑𝐴
𝑑𝑡
=
𝑘13𝑘15
𝑘10𝑘14
(𝑘9 +
𝐾7𝐷
𝐾8+𝐷
)  + 𝑘16(𝐴𝑒 − 𝐴)                                  (18) 
Finally, substituting for D from Equation (6) into equations (15) and (18) gives the two-state model: 
                                           
𝑑𝑅
𝑑𝑡
=
𝑘11
𝑘6
(𝑘5 +
𝐾3𝐴
2𝑅2
𝐾4 
𝐾1
2𝐾2
+𝐴2𝑅2
)  − 𝑘12𝑅                            (19) 
                                        
𝑑𝐴
𝑑𝑡
=
𝑘13𝑘15
𝑘10𝑘14
(𝑘9 +
𝐾7𝐴
2𝑅2
𝐾8
𝐾1
2𝐾2
+𝐴2𝑅2
)+ 𝑘16(𝐴𝑒 − 𝐴)                                  (20) 
The parameter values from [59] are reported in Table 3.  
 
Table 3: Parameters value in the model [59] 
Parameters Value Parameters Value 
𝒌𝟏 10
-4 nM-1s-1 𝒌𝟗 1.5×10
-4 nMs-1 
𝒌−𝟏 3×10
-3 s-1 𝒌𝟏𝟎 6×10
-3 s-1 
𝒌𝟐 10
-5 nM-1s-1 𝒌𝟏𝟏 1.28×10
-2 s-1 
𝒌−𝟐 10
-2 s-1 𝒌𝟏𝟐 2×10
-4 s-1 
𝑲𝟑 4.8×10
-3 nMs-1 𝒌𝟏𝟑 1.6×10
-2 s-1 
𝑲𝟒 1 nM 𝒌𝟏𝟒 5×10
-5  s-1 
𝒌𝟓 3×10
-4 nMs-1 𝒌𝟏𝟓 0.45 s
-1 
𝒌𝟔 6×10
-3 s-1 𝒌𝟏𝟔 0.4 s
-1 
𝑲𝟕 2×10
-3  nMs-1   
𝑲𝟖 30  nM   
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The authors of [59] explored the behaviour of a range of model variants, with a focus on the switch-
like behaviour of the system. Here, we take an alternative approach to model analysis; our focus is on 
the sensitivity of the system’s performance measures to the values of the model parameters. While we 
do not expect the results of this analysis to be quantitatively accurate, the results will identify the key 
parameters to be considered in designing our system. To simplify our parametric sensitivity analysis, 
we lump the model parameters as follows (values in Table 4, below):  
 
                                                                    𝐾𝑅1 =
𝑘11𝑘5
𝑘6
                                                                     (21) 
                                                    𝐾𝑅3 = √
𝐾4
𝐾1
2𝐾2
    𝐾𝑅2 =
𝐾3𝑘11
𝑘6
  ,                                        (22) 
                                                                       𝐾𝐴1 =
𝑘15𝑘13
𝑘10𝑘14
𝑘9,                                    (23) 
                                                        𝐾𝐴3 = √
𝐾8
𝐾1
2𝐾2
    and     𝐾𝐴2 =
𝑘15𝑘13𝐾7
𝑘10𝑘14
 ,                    (24) 
This gives a simplified model formulation, from Equations (19) and (20): 
                                               
𝑑𝑅
𝑑𝑡
= 𝐾𝑅1 +
𝐾𝑅2(
𝐴𝑅
𝐾𝑅3
)
2
1+(
𝐴𝑅
𝐾𝑅3
)
2 − 𝑘12𝑅                                                                     (25) 
                                          
𝑑𝐴
𝑑𝑡
= 𝐾𝐴1 +
𝐾𝐴2(
𝐴𝑅
𝐾𝐴3
)
2
1+(
𝐴𝑅
𝐾𝐴3
)
2 + 𝑘16(𝐴𝑒 − 𝐴)                                                (26) 
These lumped parameters can be interpreted as follows: expression of LuxR (and consequently, 
production of AHL) are determined by Hill functions, with Hill coefficient of 2 and Hill constants equal 
to KR3 and KA3, respectively.  Parameters 𝐾𝑅1 and 𝐾𝐴1 are the basal rates of constitutive expression from 
the two genes, while 𝐾𝑅2 and 𝐾𝐴2 are the maximal rates of activated expression.  
In comparing the behaviour of the model to experimental observation, we will most likely be 
observing the system via a target gene (e.g. gfp) that is controlled by the quorum sensing system. The 
concentration (G) of such a protein can be modeled as: 
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𝑑𝐺
𝑑𝑡
= 𝐾𝐺1 +
𝐾𝐺2(
𝐴𝑅
𝐾𝐺3
)
2
1+(
𝐴𝑅
𝐾𝐺3
)
2 − 𝑘𝐺14𝑅                                                            (27) 
for appropriate parameters 𝐾𝐺1, 𝐾𝐺2 and 𝐾𝐺14.  Because this equation has the same form as Equation 
(25), we will simplify the analysis by assuming that the dynamics of such a target protein product would 
be identical to the LuxR dynamics.  
 
Table 4: Values of lumped parameters 
Parameters Value Parameters Value 
KR1 6.4×10-4 nMs
-1 KA2 24 nMs
-1 
KR2 0.0102 nMs
-1 KA3 519.6152 nM
2 
KR3 948.6833 nM
2 K12 2×10-4 s
-1 
KA1 3.6 nMs
-1 K16 0.4 s
-1 
 
3.2.2 Analysis of the Goryachev and Lee model of gram negative quorum 
sensing system 
The analysis described in this section is novel. The mathematical model in Equations (25) and (26), 
with parameter values in Table 4, was implemented in Matlab [82].  MATLAB’s ode45 function was 
used to simulate the system of ODE’s . The extracellular concentration of AHL (Ae) was taken as an 
external input, and was considered as representative of the local bacteria population density. 
 
Before performing a sensitivity analysis, we confirm the model’s dynamic behaviour. Figure 8 and 
9 show phase portraits of the model at two different extracellular concentrations of AHL.  As Figure 8 
shows, when Ae is equal to 50 nM. all trajectories converge to a unique stable state; the  system is 
monostable. In contrast, Figure 9 illustrates that the system exhibits bistability at the lower extracellular 
AHL concentration of 25 nM. These two cases indicate the system’s potential behaviours: a bistable 
switch at lower AHL (lower density), and a monostable system (with the switch ‘flipped on’) at higher 
  32 
AHL (higher density).  The system also exhibits monostable (‘off’) behaviour below a threshold AHL 
level, as shown below. 
 
 
Figure 8: Phase portrait of Goryachev and Lee model at  
extracellular concentration of AHL equal to 50 nM. The system is monostable. 
 
 
Figure 9: Phase portrait of Goryachev and Lee model at  
extracellular concentration equal to 25 nM. The system is bistable. 
 
To further explore the change in system behaviour as we ran simulations over a range of AHL (Ae) 
values. To test for bistability, at each AHL concentration, the model was run to equilibrium from two 
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initial conditions: one in which intracellular LuxR and AHL levels are low, both equal to 1 nM  (an 
‘off’ state), and one in which these levels are high, both equal to 10 nM  (an ‘on’ state).  The steady-
state results of these simulations are shown in Figure 10, which is a bifurcation diagram for the model. 
Similar to Figure 8 above, the system exhibits monostability at low bacteria concentration, when there 
is insufficient activity to generate a response. As the AHL concentration is increased, the system enters 
a range of bistablity (for 19<Ae<29 nM).  
 
In summary: at low bacteria concentration (19<Ae) the genetic circuit is ‘off’ and for high bacteria 
concentration (29 <Ae) system becomes ‘on’. As the bacteria grow, Ae increases and when the bacteria 
concentration reaches a threshold (Ae=29nM) the system jumps to the high equilibrium point and the 
genetic circuit becomes ‘on’.  
 
 
 
 
 
 
 
Figure 10: Bifurcation diagram of V. fischeri quorum sensing  model.  
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As the figure shows, the system exhibits hysteresis – reducing the AHL level once the system is ‘on’ 
will not return the cell to the LuxR-low AHL-low state at the same threshold at which the system 
jumped to the ‘on’ state. 
 
The bifurcation structure in Figure 10 is further explored in Figure 11, which is a phase portrait 
showing nullclines of R and A for various values of Ae. For external AHL concentrations in the range 
from 19 nM <Ae<29 nM, the nullclines intersect three times, indicating the existence of three 
equilibrium points, two stable and one unstable. Parameters that alter the shape of these nullclines can 
have significant impact on the bifurcation values. 
 
 
 
Figure 11: Nullclines of model (25-26) at five different external AHL concentrations (Ae). The R 
nullcline is shown in cyan and A nullclines in blue, red, black, magenta and green. Filled and empty 
circles indicate stable and non-stable equilibrium points, respectively. For Ae between 19 nM and 29 
nM, the system is bistable.  Above this interval, only the active (high-R, high-A) state is present and 
below this interval only the off state is present. 
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As mentioned above, in planning to use a quorum sensing system to trigger aerotolerance at the site 
of solid tumors, we focus on two key performance measures: (i) the threshold concentration of external 
AHL at which the system switches to the ‘on’ state, and (ii) the steady-state concentration of the 
aerotolerance enzyme. We next explore the role of the model parameters, i.e. the design parameters, in 
tuning system performance.  
From a design perspective, natural tuning parameters are the promoter strength and ribosome binding 
site (RBS) of LuxR and LuxI.  These should have a significant impact on system behavior, and can take 
a range of values corresponding to choice of promoter and RBS. Indeed, as discussed in [83] and [84], 
changes in the strength of a promoter may alter protein production rate by 1000-fold, while changing 
the RBS site (and corresponding intergenic region) can have a 100 fold effect.  
 A preliminary analysis of the role of promoter strength is shown in Figure 12, in which system 
bifurcation curves are shown for three different values of LuxI and LuxR promoter strength. (To aid in 
comparing the curves, only the ‘turning on’ branch of the full bifurcation plot is shown. That is, these 
equilibria are all reached from the ‘off’ initial state.)    
  
Figure 12:  Bifurcation diagrams showing the effects of changes in the promoter strength of the luxR 
and luxI genes. Strong, medium and weak luxR promoters correspond to 𝒌𝟑 values of  9.6×10
-3 , 
4.8×10-3 2.4×10-3 nMs-1 , respectively. Strong, medium and weak luxI promoters correspond to 𝒌𝟕 
values of  9.6×10-3 , 4.8×10-3 2.4×10-3 nMs-1, respectively. The threshold concentration can be tuned 
by both promoter strengths. The final concentration of LuxR can be only tuned by strength of luxR 
promoter 
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The figure shows that the threshold concentration can be tuned by changing the strength of either 
promoter. In contrast, the final concentration of LuxR can be tuned by the choice of luxR promoter, 
but it is insensitive to the strength of the luxI promoter.  This insensitivity can be of value in a design 
strategy, since it allows the concentration threshold to be tuned (via the luxI promoter) separately 
from tuning of the threshold AHL concentration. An analysis of the RBS strength (not shown) reveals 
a similar effect. This is not surprising, since these parameters play similar roles in describing protein 
production in the model.   
3.2.3 Parametric Sensitivity Analysis  
The above analysis sheds some light on the behavior of the system, but addresses the effects of only a 
few design parameters, and, significantly, may be dependent on the chosen nominal values of the model 
parameters.  Though these nominal values were justified in [59] and [60], they cannot be trusted to be 
more than estimates of the true representation of the system.  To provide more robust design 
recommendations, a globalized sensitivity analysis was carried out on the system. For each parameter 
Pi , two local sensitivity coefficients are defined  
                     𝑆𝑠𝑠 =
𝑃𝑖
𝐶𝑚𝑎𝑥
𝜕𝐶𝑚𝑎𝑥
𝜕𝑃𝑖
 
   and   𝑆𝑡ℎ𝑟𝑒𝑠ℎ =
𝑃𝑖
𝐶𝑡ℎ𝑟𝑒𝑠
𝜕𝐶𝑡ℎ𝑟𝑒𝑠ℎ
𝜕𝑃𝑖
                (28) 
where 𝑆𝑠𝑠 and  𝑆𝑡ℎ𝑟𝑒𝑠ℎ represent the sensitivity of the steady-state concentration of LuxR and the 
AHL threshold concentration (off-to-on), respectively. These derivatives are approximated as finite 
differences, by simulating the effect of a 10 percent change in parameter values as follows: 
𝑆𝑠𝑠 =
𝑃𝑖
𝐶𝑚𝑎𝑥(𝑃𝑖)
𝐶𝑚𝑎𝑥(𝑃𝑖+0.1∗𝑃𝑖)−𝐶𝑚𝑎𝑥(𝑃𝑖)
0.1∗𝑃𝑖
 
   and   𝑆𝑡ℎ𝑟𝑒𝑠ℎ =
𝑃𝑖
𝐶𝑡ℎ𝑟𝑒𝑠(𝑃𝑖)
𝐶𝑡ℎ𝑟𝑒𝑠(𝑃𝑖+0.1∗𝑃𝑖)−𝐶𝑡ℎ𝑟𝑒𝑠(𝑃𝑖)
0.1∗𝑃𝑖
      (29) 
In order to carry out globalized analysis, for each parameter presented in Table 3, the bistability range 
was determined. These ranges are reported in Table 3.  Because sampling over a fine mesh in the 8-
dimensional parameter spaces would be prohibitively time-consuming, two values were chosen for each 
parameter: at the ends of the bistability region. Local sensitivity coefficients were calculated at the 
corresponding 256 (=28) points in parameter space. For each parameter, these were then averaged to 
give a single globalized sensitivity coefficient. These are reported in Table 5.  
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Table 5: Globalized sensitivity analysis on Gram negative QS mechanism 
Parameters Bistability Range 𝑆𝑠𝑠 𝑆𝑡ℎ𝑟𝑒𝑠ℎ 
𝑲𝑹𝟏 (𝟏 − 𝟒) × 𝟏𝟎
−𝟒 nMs-1 0.0147 -0.7387 
𝑲𝑹𝟐 (𝟏 − 𝟒) × 𝟏𝟎
−𝟐 nMs-1 0.9877 -0.5675 
𝑲𝑹𝟑 𝟖𝟎𝟎 − 𝟏𝟓𝟎𝟎  nM
2 -0.0025 1.2096 
𝑲𝑨𝟏 0.01-4  nMs
-1 0.00001 -0.1749 
𝑲𝑨𝟐 10-90   nMs
-1 0.0005 -0.1343 
𝑲𝑨𝟑 100-900 nM
2 0 0 
𝒌𝟏𝟐 (𝟏 − 𝟐. 𝟑) × 𝟏𝟎
−𝟒 s-1 -0.9028 1.3529 
𝒌𝟏𝟔 (𝟑 − 𝟗) × 𝟏𝟎
−𝟏 s-1 -0.0006 0.2061 
 
This globalized sensitivity analysis indicates that (i) the steady-state LuxR concentration is most 
sensitive to the maximal induced expression rate of LuxR (𝑲𝑹𝟐) and the  degradation rate of LuxR ( 
𝒌𝟏𝟐)  while (ii) the threshold AHL concentration is most sensitive to the dissociation constant for LuxR 
activation (𝑲𝑹𝟑) and  degradation rate of LuxR (𝒌𝟏𝟐) , and is moderately sensitive to the basal LuxR 
expression rate  (𝑲𝑹𝟏).   Importantly, consistent with the observation in the preliminary analysis, the 
analysis reveals that the dissociation constant for LuxR activation (𝑲𝑹𝟑)  could be used to tune the 
activation threshold without affecting the steady-state AHL level. While tuning of this parameter value 
introduces its own design challenges (e.g. by introducing point mutations to the LuxI gene), the 
independent effect revealed by this analysis could be exploited in the design phase. 
The analysis in Table 5 addresses the lumped parameters from the simplified model (25-26). To 
identify how these effects are related to the kinetic parameters in the original model, we carried out a 
secondary analysis. To identify the contributions to the sensitivity of RBS strength and promoter 
strength, another sensitivity analysis was carried out on parameters 𝒌𝟏𝟑 ,  𝒌𝟏𝟓  , 𝒌𝟔 and 𝒌𝟏𝟎  which 
characterize the RBS and promoter strength of the luxR and luxI genes. For each parameter, three values 
were chosen: the two endpoints and the midpoint of the bistability region. Local sensitivities were 
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calculated for each parameter at the corresponding 81 points of parameter space, and again the overall 
sensitivity of each parameter was calculated by averaging. The results are shown in Table 6. 
 
Table 6: Sensitivity analysis on RBS and promoter strength parameter 
Parameters  Range 𝑆𝑠𝑠 𝑆𝑡ℎ𝑟𝑒𝑠ℎ 
𝒌𝟔    PluxR (𝟐 − 𝟓) × 𝟏𝟎
−𝟑   s-1 1.1627     -0.4935    
𝒌𝟏𝟎    PluxI (𝟐. 𝟒 − 𝟗. 𝟔) × 𝟏𝟎
−𝟑  s-1 0.1590     -0.0494    
𝒌𝟏𝟑    RBSluxR (𝟏 − 𝟐) × 𝟏𝟎
−𝟐  s-1 2.3556     -0.7935    
𝒌𝟏𝟓    RBSluxI (𝟎. 𝟖 − 𝟐. 𝟒) × 𝟏𝟎
−𝟐  s-1 0.2168          -0.0672 
 
This analysis confirms the result of Figure 12. The steady-state concentration of LuxR is not sensitive 
to luxI promoter or RBS strength. Moreover, the most significant parameter for the steady-state 
concentration of LuxR and AHL threshold concentration is the RBS strength of luxR. The AHL 
threshold concentration is sensitive to the RBS and promoter strength of luxR. Neither threshold 
concentration nor final value concentration are sensitive to the parameters of luxI production. Changes 
in the luxR RBS and promoter strength will have opposite effects on the AHL threshold concentration 
and steady state concentration of luxR. Therefore, if we want to increase the threshold concentration, 
decreasing the luxR promoter or RBS strength may increase the threshold concentration but will 
decrease the final concentration of aerotolerance enzyme. Haseltine and Arnold studied analytically 
and experimentally the effect of changing luxR RBS on the threshold concentration and obtained similar 
results [85]. These results imply that in the plasmid construction that we have selected, in order to tune 
the threshold concentration we should carefully consider the choice of luxR RBS and promoter strength, 
which will result in a trade-off effect on the final concentration of the aerotolerance enzyme. 
Having discussed quorum sensing in gram-negative organisms, we next turn to a complementary 
model-based analysis of a gram positive quorum sensing system. 
3.3.1 Mathematical Model of Quorum Sensing in Gram Positive Bacteria 
As reviewed in Section 2.5.2 the quorum sensing mechanism of S. aureus is a canonical example of 
the gram positive quorum sensing system. There are four different strains of S. aureus, each of which 
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produces a strain-specific autoinducer peptides (AIP). Each AIP activates its own AgrC receptor and 
inhibits the activity of the receptors in the other strains.  
 
Here we investigate a mathematical model of the quorum sensing mechanism of S. aureus introduced 
in [62].  
The model formulation is as follows. Binding of the native (P) and any non-native (X) autoinducer 
peptides to the sensor receptor AgrC (C) can be described by the following reactions:  
                                                  𝐶 + 𝑃
𝑘𝑐1
⇌
𝑘𝑐2
𝐶𝑝
𝑑𝑐𝑝
→                                    (30) 
                                                  𝐶 + 𝑋
𝑘𝑐3
⇌
𝑘𝑐4
𝐶𝑥
𝑑𝑐𝑥
→                                                             (31) 
where 𝐶𝑝 and 𝐶𝑥  are active and inactive AgrC receptor, respectively, 𝑘𝑐1 and 𝑘𝑐3 are association 
rates, 𝑘𝑐2 and 𝑘𝑐4 are dissociation rates and 𝑑𝑐𝑝 and 𝑑𝑐𝑥 are degradation rates. 
The ODE’s governing these reactions are as follows: 
                                                  
𝑑𝐶𝑝
𝑑𝑡
= 𝑘𝑐1𝐶𝑃 − 𝑘𝑐2𝐶𝑝 − 𝑑𝑐𝑝𝐶𝑝                    (32) 
                                                
𝑑𝐶𝑥
𝑑𝑡
= 𝑘𝑐3𝐶𝑋 − 𝑘𝑐4𝐶𝑋 − 𝑑𝑐𝑝𝐶𝑋                     (33) 
Considering quasi steady state assumption for Cp and Cx we have  
                                                 𝐶𝑝 =
𝑘𝑐1𝐶𝑃
𝑘𝑐2+𝑑𝑐𝑝
= 𝐾𝑐𝑝𝐶𝑃                      (34) 
                                                  𝐶𝑥 =
𝑘𝑐3𝐶𝑋
𝑘𝑐4+𝑑𝑐𝑥
= 𝐾𝑐𝑥𝐶𝑋                      (35) 
where   𝐾𝑐𝑝 =
𝑘𝑐1
𝑘𝑐2+𝑑𝑐𝑝
      and          𝐾𝑐𝑥 =
𝑘𝑐3
𝑘𝑐4+𝑑𝑐𝑥
  
The phosphorylation of AgrA (A) by AgrC (C) can be described by the following reactions: 
                                                  
𝐶𝑝
↓
𝑑𝐴
← 𝐴
𝑘𝑝
⇌
𝑘𝑑𝑝
𝐴𝑝
𝑑𝐴𝑝
→ 
                       (36) 
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where 𝐴𝑝 is the phosphorylated form of AgrA,  𝑘𝑝 and 𝑘𝑑𝑝 are phosphorylation and 
dephosphorylation rates of AgrA, 𝑑𝐴 and 𝑑𝐴𝑝 are degradation of AgrA and phosphorylated AgrA, 
respectively. 
Reaction (36) provide the following description of the phosphorylated form AgrA ( 𝐴𝑝): 
                                                  
𝑑𝐴𝑝
𝑑𝑡
= 𝑘𝑝𝐶𝑝𝐴 − 𝑘𝑑𝑝𝐴𝑝 − 𝑑𝐴𝑝𝐴𝑝                    (37) 
Assuming quasi steady state for 𝐴𝑝 gives: 
                                                  𝐴𝑝 =
𝑘𝑝𝐾𝑐𝑝     
𝑘𝑑𝑝+𝑑𝐴𝑝
𝐶𝑃 ⇒     𝐴𝑝 = 𝐾𝑝𝐶𝑃𝐴                                 (38) 
where   𝐾𝑝 =
𝑘𝑝𝐾𝑐𝑝     
𝑘𝑑𝑝+𝑑𝐴𝑝
 
Since the transcription factor of agr operon is a monomer, we can model the dynamics of AgrA as 
[62]: 
                                
𝑑𝐴
𝑑𝑡
= 𝑘𝐴
𝐴𝑝
𝐾𝐴𝑝
1+
𝐴𝑝
𝐾𝐴𝑝
+ 𝑘𝐴𝑝𝑟𝑖𝑚𝑒 − 𝑘𝑝𝐶𝑝𝐴 + 𝑘𝑑𝑝𝐴𝑝 − 𝑑𝐴𝐴                                        (39) 
where 𝑘𝐴𝑝𝑟𝑖𝑚𝑒 is basal transcription rate of expression, 𝑘𝐴 is the maximal rate of activated 
expression,  𝐾𝐴𝑝 is the Michaelis constant of activator binding, and   𝑑𝐴 is the degradation rate for 
AgrA.   
 Substituting 𝐴𝑝 and 𝐶𝑝from Equation (38) and (34) into equation (39) yields: 
                               
𝑑𝐴
𝑑𝑡
= 𝑘𝐴
𝐾𝑝
𝐾𝐴𝑝
𝐶𝑃𝐴
1+
𝐾𝑝
𝐾𝐴𝑝
𝐶𝑃𝐴
+ 𝑘𝐴𝑝𝑟𝑖𝑚𝑒 − (𝑘𝑝𝐾𝑐𝑝𝐶𝑃 − 𝑘𝑑𝑝𝐾𝑝𝐶𝑃 + 𝑑𝐴)𝐴                        (40) 
Because AgrC and AgrA are share a common promoter, the transcription of AgrC follows the same 
kinetic as AgrA. The dynamics of AgrC (𝐶) can be similarly modeled as follows: 
                      
𝑑𝐶
𝑑𝑡
= 𝑘𝐶
𝐾𝑝
𝐾𝐴𝑝
𝐶𝑃𝐴
1+
𝐾𝑝
𝐾𝐴𝑝
𝐶𝑃𝐴
+ 𝑘𝐶𝑝𝑟𝑖𝑚𝑒 − 𝑘𝑐1𝐶𝑃 + 𝑘𝑐2𝐶𝑝 − 𝑘𝑐3𝐶𝑋 + 𝑘𝑐4𝐶𝑐𝑥 − 𝑑𝑐𝐶                (41) 
where 𝑘𝐶𝑝𝑟𝑖𝑚𝑒 is basal transcription rate for AgrC (𝐶), 𝑘𝐶 is the maximal rate of activated expression 
and   𝑑𝐶 is the degradation rate for AgrC.   
Substituting 𝐶𝑝 and 𝐶𝑥 from equations (34) and (35) into equation (41) yields: 
                 
𝑑𝐶
𝑑𝑡
= 𝑘𝐶
𝐾𝑝
𝐾𝐴𝑝
𝐶𝑃𝐴
1+
𝐾𝑝
𝐾𝐴𝑝𝐶𝑃
𝐴
+ 𝑘𝐶𝑝𝑟𝑖𝑚𝑒 − (𝑘𝑐1𝑃 − 𝑘𝑐2𝐾𝑐𝑝𝑃 + 𝑘𝑐3𝑋 − 𝑘𝑐4𝐾𝑐𝑥𝑋 + 𝑑𝑐)𝐶               (42) 
The concentration of AgrD (𝐷) can be described as: 
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𝑑𝐷
𝑑𝑡
= 𝑘𝐷
𝐾𝑝
𝐾𝐴𝑝
𝐶𝑃𝐴
1+
𝐾𝑝
𝐾𝐴𝑝
𝐶𝑃𝐴
+ 𝑘𝐷𝑝𝑟𝑖𝑚𝑒 − 𝑑𝐵𝐷                                                                  (43) 
where 𝑘𝐷𝑝𝑟𝑖𝑚𝑒 is basal transcription rate for AgrD (𝐷), 𝑘𝐷 is the maximal rate of activated expression 
and   𝑑𝐵 is the degradation rate for AgrD.   
Assuming a linear kinetic for the production of AIP (𝑃) from ArgD we have 
                                          
𝑑𝑃
𝑑𝑡
= 𝑘𝐷𝑝𝐷 − 𝑑𝑃𝑃                      (44) 
here 𝑘𝐷𝑝 is the production rate and 𝑑𝑃 the degradation rate of AIP (𝑃). Ignoring the dynamics of AHL 
export by AgrB, we assume that all AIP is rapidly exported to the extracellular space.  
Parameter values for the model are given in Table 7. 
 
Table 7: Parameters value in the model [62] 
Parameters Value Parameter Value 
𝒌𝑨 10s
-1 𝑲𝑪𝑷 5×10
-5 s-1 
𝑘𝐴𝑝𝑟𝑖𝑚𝑒 0.1 s
-1 𝑲𝑪𝒙 0.45 s
-1 
𝒌𝑪 10s
-1 𝒅𝑨 2s
-1 
𝑘𝐶𝑝𝑟𝑖𝑚𝑒 0.1 s
-1 𝒅𝑪 2 s
-1 
𝒌𝑫 10s
-1 𝒅𝑨𝒑 2  s
-1 
𝑘𝐷𝑝𝑟𝑖𝑚𝑒 0.1 s
-1 𝒅𝑪𝒑 2  s
-1 
𝒌𝒄𝟏 1 nM
-1 s-1 𝒅𝑪𝒙 2  s
-1 
𝒌𝒄𝟐 0.1 s
-1 𝑲𝑨𝑷 1 nM 
𝒌𝒄𝟑 1 nM
-1s-1 𝑲𝑪𝒑 0.48 s
-1 
𝒌𝒄𝟒 0.1 s
-1 𝑲𝑪𝒙 0.48 s
-1 
𝒌𝒑 10 nM
-1s-1 𝑲𝑷 1.59 s
-1 
𝒌𝒅𝒑 1  s
-1   
 
3.3.2 Analysis of Quorum Sensing in Gram Positive Bacteria  
The analysis described in this section is novel. The mathematical model in Equations (40), (42), (43) 
and (44), with parameter values in Table 7, derived from [62], was implemented in Matlab [82].  
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MATLAB’s ode45 function was used to simulate the system of ODE’s . The AIP concentration (P) 
was taken as an external input, and is considered as representative of the local bacterial population 
density. 
 
The model behaviour is similar to the bistable behaviour exhibited by the model of gram negative 
quorum sensing that was presented in section 3.1. Although this model is not 2-dimensional, phase 
portraits can still be generated by projecting the trajectories onto a 2-dimensional plane showing the 
AgrA-AgrC dynamics. Figure 13 and 14 show representative phase portraits for the monostable and 
bistable regions, respectively. In figure 13 the AIP concentration is taken equal to 1.5 nM, which is 
located in monostable (‘on’) region. As the figure shows, all trajectories converge toward a single stable 
point.   
 
Figure 13: Phase portrait of the system at monostable region,  
AIP concentration equal  to 1.5 nM 
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In Figure 14 the AIP concentration is taken equal to 0.5 nM which is located in the bistable 
(switching) region. The figure illustrates that the system exhibits bistability: the trajectories of the 
system converge toward two different stable points depending on the initial condition. 
 
Figure 14: Phase portrait of the system at bistable region  
AIP concentration equal  to 0.5 nM 
 
The bifurcation behaviour of the model is illustrated in Figure 15. To generate this figure, simulations 
were run for a range of AIP values. In each case, the model was run to equilibrium from two initial 
conditions: one in which AgrC and AgrA levels are low (an ‘off’ state, both equal to 0.1 nM ), and one 
in which these levels are high (an ‘on’ state, both equal to 5 nM ).  
As shown in the figure, the system exhibits monostability at low bacterial concentration (P<0.2 nM) 
and at high bacterial concentration (P>1 nM). It exhibits bistable behavour for the intermediate range 
0.2 nM < P <1 nM. At low bacterial concentration the genetic circuit is always ‘off’; for high bacteria 
concentrations it is always ‘on’. As a culture grows, the AIP concentration increases; when the bacterial 
concentration reaches a threshold (P=0.2 nM), the system jumps to the high equilibrium point and the 
genetic circuit becomes ‘on’.  As the figure shows, the system exhibits hysteresis–it does not return to 
‘off’ state at the same point as it jumps to ‘on’ state. 
Figure 16 shows the nullclines of the model in the absence of AIP. This is representative of the 
behaviour at low AIP concentration (P<0.2): one equilibrium point at the ‘off’ state. 
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The system nullclines at AIP concentration equal to 1.5 nM (representing high AIP concentration) 
are shown in Figure 17. Again, the system is monostable: it has one stable equilibrium point at the ‘on’ 
state.  
 
Figure 15: Bifurcation diagram of  the S. aureus QS mechanism,  
the initial values of phosphorylated AgrA (A) and AgrC(C)  
are equal to 0.1nM for low initial value and 5 nM for high initial value 
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Figure 16:  Nullclines of model (40) and (42) in the absence of AIP concentrations (P).  
Filled circle indicate the stable equilibrium point.  
For P less than 0.2 nM the system is monostable at off state. 
 
Figure 17:  Nullclines of model (40) and (42) at AIP concentrations (P) equal to 1.5 nM. Filled circle 
indicate the stable equilibrium point. For P higher than 1 nM the system is monostable at on state. 
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Figure 18 Nullclines of model (40) and (42) at AIP concentrations (P) equal to 0.5 nM.  
Filled and empty circles indicate the stable and non-stable equilibrium points, respectively. 
 The system is bistable at the intermediate concentration of AIP (0.2<P<1 nM).  
 
At AIP concentration equal to 0.5 nM, the system has two stable  and one unstable equilibrium 
points, as illustrated in  Figure 18 . The nullclines of the model have similar shape at intermediate 
concentration of AIP (0.2<P<1 nM). 
We next consider the effect of variation in parameter values on the system behaviour. As in section 
3.1, our focus is on two key performance measures: the threshold value of AIP (at which the switch to 
the ‘on’ state occurs), and the steady state activity level (the phosphorylated AgrA concentration). 
Figure 19 shows a preliminary analysis of the role of ribosome binding site (RBS) strength. Variation 
in the RBS strength of AgrA and AgrC is characterized by changes parameters kA and kC respectively.  
System bifurcation curves are shown over three different values of AgrC and AgrA RBS strengths.  
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Figure 19 The effects of changes in the ribosome binding strength of AgrA and AgrC.  
Strong, medium and weak  AgrA  and AgrC RBS’s correspond to 𝒌𝑨 and 𝒌𝑪 equal to  30 , 10 and 5
 
nMs-1 , respectively. The threshold concentration can be tuned by both RBS strength while the final 
concentration of the transcription factor can be more effectively tuned by strength of AgrC RBS 
 
The figure illustrates that as the strengths of AgrA and AgrC ribosome binding sites increase (increasing 
kA, and kC respectively), the threshold concentration decreases and the final value of transcription factor 
(Ap ) increases.  But the effect of RBS strength of AgrC (KC) on the final concentration is more 
significant than the effect of RBS strength of  AgrC (KC).   
 
Figure 20 shows the effect of inhibitor autoinducer on the system dynamics.  Since our ultimate goal is 
to engineer quorum sensing mechanism of S. aureus into C. sporogenes, it is of value to know the effect 
that inhibitory AIP may have on the engineered system.   As shown in the figure, the inhibitor moves 
the bifurcation points and hysteresis loop to the right, and increases the threshold concentration, but 
has a minor effect on the final concentration.  
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Figure 20:  System behavior for different non-native AIP concentration 
 
3.3.3 Parametric Sensitivity Analysis  
As in section 3.1, we aim to identify parameters that have significant influence over the system’s 
performance. To obtain robust conclusions, a globalized analysis was carried out over the parameters 
presented in Table 7. Because sampling over a mesh in the 16-dimensional parameter spaces would be 
prohibitively expensive, two values were chosen for 7 parameters that we can tune using molecular 
biology techniques. Each parameter was sampled at the endpoints of the corresponding bistability 
region, as determined using MATLAB [82]. The other parameters were assigned their nominal values 
(Table 8). As in Section 3.2.3, Equation (28) was used to define local sensitivity coefficients for each 
parameter  Pi   where 𝑆𝑠𝑠 and  𝑆𝑡ℎ𝑟𝑒𝑠ℎ represent the sensitivity of the steady-state concentration of 
phosphorylated AgrA (𝐴𝑝) and the AIP (𝑃) threshold concentration, respectively. Equation (29) was 
used to estimate the derivatives based on 10 percent change in parameter values.  
Consequently, the local sensitivity coefficients were calculated at 128 (=27) points in the parameter 
space. For each parameter, these were then averaged to give a single globalized sensitivity coefficient. 
These are reported in Table  8.  
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Table 8: Globalized sensitivity analysis of gram negative quorum sensing mechanism 
Parameters Bistability Range 𝑆𝑠𝑠 𝑆𝑡ℎ𝑟𝑒𝑠ℎ 
𝑲𝒑 5 − 15 -0.0749 -1.1763 
𝒌𝒄 5-15 1.5685 -1.2223 
𝒌𝑨 5-15 -0.3368 -0.2313 
𝒌𝑨𝒑𝒓𝒊𝒎𝒆 .05-0.15 0.2726 -0.2352 
𝒌𝑪𝒑𝒓𝒊𝒎𝒆 .05-0.15 0.2073 -0.9171 
𝒅𝑪 1.5-3 0.0902 1.0988 
𝒅𝑨 1.5 − 3 -0.7420 1.3924 
𝑲𝑨𝑷 1 -0.7969 1.8490 
𝒌𝒄𝟏 1 -0.0186 -0.8906 
𝒌𝒄𝟐 0.1 -0.0159 0.0208 
𝒌𝒄𝟑 1 0 0 
𝒌𝒄𝟒 0.1 0 0 
𝒌𝒅𝒑 1 0.0158 0.4809 
𝒅𝒄𝒑 2 0.0724 1.3771 
𝒅𝑨𝒑 2 -0.8389 1.2981 
 
The threshold value of AIP is most sensitive to 𝑲𝑨𝑷, the Michaelis constant for activator binding, 
and is also highly sensitive to the degradation rates for AgrA and AgrC (in both unphosphorylated and 
phosphorylated forms, 𝒅𝑪, 𝒅𝑪, 𝒅𝒄𝒑, 𝒅𝑨𝒑). This threshold is also sensitive to parameter kc, which 
characterizes the maximal activated expression rate of AgrC. The steady state activity level (i.e. steady 
state phosphorylated AgrA concentration), is sensitive to the same parameters, with the noteworthy 
exception of the rate of degradation of AgrC (𝒅𝑪 and 𝒅𝑪𝒑). 
This analysis presents some design strategies for manipulation of the steady-state activity (e.g. tuning 
of the degradation rate of AgrA or expression rate of AgrC), and an avenue for separate adjustment of 
the threshold AIP level (via tuning of the rate of degradation of AgrC). 
These results are complementary to our findings in Section 3.3.2. Together, they provide a useful set 
of strategies for the design of quorum sensing systems as functional switches to trigger desired activity. 
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Chapter 4 
Mathematical Model and Sensitivity Analysis of Aerotolerant 
Bacteria Growth in Solid Tumors 
4.1 Introduction 
The results in this chapter were published in [86]. In Section 2.2 the structure of solid tumor was 
explained. In solid tumors, the proliferation of abnormal cells is much faster than development of 
vasculature; therefore, the inner part of the tumor becomes avascular. This phenomenon together with 
the abnormality in lymphatic and blood vessels makes the inner part of the tumor hypoxic [87].  
Hypoxia imposes a barrier for conventional cancer therapies such as chemotherapy and radiotherapy.  
Conversely, it is the mechanism for specificity in a bacteria-mediated therapy, since the hypoxic part 
of a tumor provides an attractive site of colonization for anaerobic bacteria such as C. sporogenes. 
Intravenous injection of C. sporogenes into tumor-bearing mice shows that the bacteria can germinate 
in a tumor up to a density of 2×108 C.F.U./g, with resulting oncolysis [88].  Bacterial expression of a 
therapeutic agent such as nitrogen reductase (NTR) or cytosine deaminase (CD) can further enhance 
oncolysis. 
As was explained in section 2.3, because anaerobic bacteria germinate only in the necrotic part of 
the tumor, tumor regrowth can occur from the outer viable rim.  This problem can be addressed by 
allowing the bacteria to migrate to less hypoxic parts of the tumor. As discussed in Chapter 2, research 
on the oxygen metabolism of anaerobic bacteria (such as Clostridium and Bifidobacterium) has shown 
that they can germinate in low oxygen environments if they are producing an NADPH oxidase, such as 
NoxA  ([43],[44],[45]). The strain C. Aminovalericum, which is able to grow in low oxygen levels, 
expresses the noxA gene at elevated levels under exposure to low oxygen conditions, indicating a role 
for NoxA in Clostridium oxygen metabolism [43].  Other candidate aerotolerance enzymes include 
nox-1 and nox-2 gene from lactic acid bacteria [89], and the nox gene from L. mesendteroides [90].  
The genome of wild-type C. sporogenes does not include a nox gene.  An engineered strain 
expressing nox constitutively would show little specificity in targeting tumors.  In order to target 
colonization, we will place the gene under the control of an inducible promoter that will be active only 
in the presence of the high-density colony in the necrotic core.  Bacterial quorum sensing mechanisms 
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provide this action: triggering the production of a gene only when the bacterial density surpasses a 
threshold.  
Bacterial quorum sensing was explained in Section 2.5. The two well-characterized quorum sensing 
mechanism are that of V. fischeri and S. aurous. While the former is known as the typical quorum 
sensing mechanism for gram negative bacteria, the latter is used as a typical one for gram positive 
bacteria. The Vibrio fischeri quorum sensing mechanism engineered in E. Coli has already been used 
to increase cell density in selective invasion of mammalian cells [78]. This mechanism can be 
introduced into C. Sporogenes by cloning the luxI and luxR genes under the control of the pLux 
promoter [51]. Figure 21 shows the proposed genetic circuit using the V. fischeri qourum sensing 
mechanism. 
 
 
 
                                                                                                                   AHL 
 
 
 
 
 
 
 
 
 
 
 
 
 
The S. aurous quorum sensing mechanism can be introduced into C. sporogenes by cloning agrA, 
agrB, agrC, agrD genes down stream of the P2 promoter. The aerotolerance enzyme gene can be cloned 
either downstream of P2 or P3 promoter. Figure 22 shows the two proposed layout of the genetic circuit 
using S. aureus quorum sensing. 
 
`Figure 21:  Proposed aerotolerant genetic 
circuit using V. Fischeri quorum sensing 
LuxR 
LuxR 
LuxI 
NoxA 
 plux 
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The engineered bacteria are expected to germinate in the necrotic part of a solid tumor at a specific 
concentration (about 108 C.F.U./g) [87]. The model-based analysis in Chapter 3 suggests strategies for 
tuning a quorum sensing mechanism to a threshold by careful design of the synthetic genetic circuit by, 
for example, modifying the ribosome binding site of the promoter or by the choice of a specific luxR 
gene [76].  As a result, the aerotolerance enzyme will not be expressed in healthy (oxygenated) tissue, 
but will be produced at the site of a tumor, allowing the local bacteria to migrate to less hypoxic parts 
of the tumor and hence enhance tumor regression.   
To complement our model-based design of the circuit, we next present a mathematical model of 
tumor colonization by the engineered strain, which will provide insight into design choices that will 
influence population-level behavior. 
4.2  Oxygen profile and tumor structure  
Tumor structure was explained in section 2.1. In this section, to simplify the geometric complexity of 
a tumor, we consider an ideal tumor as a radially symmetric sphere. 
Figure 23 shows the oxygen profile and structure of such a tumor as presented in [4]. The radii of the 
necrotic and hypoxic cores are denoted by RN and RH. Oxygen does not diffuse more than 70 µm into 
the tumor [5].  Considering a tumor with R = 90 µm, we expect to have  RN = 20 µm. The hypoxic 
radius of such a tumor is around RH = 36 µm.  The oxygen profile shown in Figure 23 is based on the 
data in [4] and is used to describe the environment in which a colony forms in the simulation in the 
P3 P2 
agrB noxA agrD agrA agrC 
P2 P3 
agrBnoxA agrD agrA agrC 
a) 
b) 
Figure 22: The proposed aerotolerant genetic circuit using S. aureus 
quorum sensing mechanism 
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next section. The oxygen level in the necrotic core is almost zero. In the quiescent or hypoxic part, the 
oxygen concentration is less than 0.33% (2.5 mmHg). Table 9 shows the data points extracted from 
information in [4]. 
 
Figure 23: Tumor structure, and oxygen profile based on the data in [4] 
 
 
Table 9: Data point for fitting Oxygen profile in Tumor based on data in [4] 
R(µm) O % PO2 (mmHg) 
0<R<20 0 0 
R=20 0 0 
R=36 0.33 2.5 
R=90 5.9 45 
R>90 5.9 45 
 
A cubic curve was fit to the data in Table 9, using the MATLAB curve fitting toolbox [82]. This 
curve is used in the next section to represent the oxygen profile as a function of radial distance r: 
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                  𝑂 = −3.044 × 10−5 × 𝑟3 + 5.116 × 10−3 × 𝑟2 − 0.165 × 𝑟 + 1.497             (45) 
where 𝑟 is in µm and oxygen in percent 
4.3 Mathematical Model of Bacterial Growth in Solid Tumors 
We consider the time-varying growth of the engineered bacterial colony in a radially symmetric 
spherical tumor.  
The degradation, production and diffusion of aerotolerance enzyme (E) and autoinducer (A) are 
modeled by reaction-diffusion equations (convective transport is negligible in tumors due to the high 
intestinal pressure, and so diffusion plays the main role in transport of molecules): 
                                         
{
 
 
 
                                                           (46)
                                                                        (47)
         
                        
The first terms on the right hand side of the equations describe diffusion. DA and DE are the diffusion 
coefficient of autoinducer and aerotolerance enzyme, respectively. Degradation of autoinducer and 
aerotolerance enzyme follow a first order kinetic with rate constants dA and dE, respectively. The rate 
of production of autoinducer is proportional to the bacterial concentration CB, with a rate constant of 
KA.  The production of the aerotolerance enzyme depends linearly on the bacterial concentration, with 
rate constant KE, and hyperbolically on the abundance of autoinducer, with a half-saturation value of k. 
The core of the quorum sensing mechanism, which is the positive feedback loop, is retained in this 
simplified model. (The model represents the quorum sensing mechanisms of both gram positive and 
gram negative bacteria. You et al. [74] used a similar simplified description of the quorum sensing 
mechanism, which lumps production of LuxR (or AgrA), production of LuxR-AHL (or AgrC-AIP) 
complex, activation of the promoter and expression of target gene.) 
The bacterial population dynamics are modeled as 
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Again, the first term describes diffusion, with DB the diffusion coefficient of the bacteria. In the 
absence of oxygen and aerotolerance enzyme, the bacteria follow density dependent growth with a 
maximal rate equal to KB and a maximal concentration of CM.  A death term, which models the effect 
of oxygen (O), increases with the oxygen concentration. The aerotolerance enzyme counteracts this 
effect. The strength of the aerotolerance enzyme is characterized by the parameter kv. (Since (kvE+1) is 
always larger than one, the denominator of the third term (death term) will never become negative.) 
To minimize the model parameter set, we non-dimensionalized the mathematical model. Considering 
AM and EM as the maximal concentration of autoinducer and aerotolerance enzyme produced by 
constitutive promoters, and TEM and TAM, their maximal life time, respectively, we scaled each variable 
in Equation (46), (47) and (48) by its maximal value to arrive at 
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where R  is the tumor radius. 
We then wrote equations (49), (50) and (51) in nondimensional form as follows: 
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The resulting dimensionless parameters are bacterial growth rate (MB), bacterial death rate (NB), AHL 
production rate (MA), AHL degradation rate (NA), aerotolerance enzyme production rate (ME), 
aerotolerance enzyme degradation rate (NE), half-saturation constant (K), strength of aerotolerance 
enzyme (Kv), diffusion coefficient of AHL (α), diffusion coefficient of aerotolance enzyme (β)  and 
diffusion coefficient of  bacteria (γ).                     
 
The mathematical model in Equations (52) - (57) and Equation (45), with parameter values in Table 
10, was implemented in Matlab [82].  MATLAB’s PDEPE function was used to solve the system of 
PDE’s (Appendix C). We simulate the situation in which a small number of spores diffuse into the 
necrotic part of the tumor and germinate, therefore we assume the initial bacterial concentration to be 
small and the initial autoinducer and aerotolerance enzyme abundance to be zero. Since the boundary 
of the tumor is well oxygenated, no anaerobic bacteria can grow at the edge of the tumor (and so no 
autoinducer or aerotolerance enzyme can be produced), therefore the concentration of all species are 
considered to be zero at the edge of the tumor (r=R).  The gradient of all species are assumed to be zero 
at the center of the tumor; therefore, for each species in the model a symmetric boundary condition is 
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applied at the center of the tumor  (r = 0) while a zero boundary condition is applied at the edge of the 
tumor (r = R).  In Equation (54), maximum production rate (MB) and maximum death rate (NB) are 
specified by the choice of host bacteria and cannot be altered by genetic circuit. We chose values for 
those parameters so that for the wild-type (that is, in the absence of the aerotolerance enzyme) 
colonization is supported only inside the necrotic and hypoxic part of the tumor.  The other parameters 
were estimating from parameters introduced in [74] and [59], using Equations (55)-(57).  
 
Table 10: parameters value in the model 
Parameters Value Parameters Value 
𝑴𝑩 20000 𝑵𝑬 0.1 
𝑴𝑬 50 𝑵𝑨 0.1 
𝑴𝑨 50 γ 0.01 
𝑲𝒗 23 𝜷 0.0001 
𝑲 0.01 𝜶 0.1 
𝑵𝑩 18500   
 
Figure 22 compares the model predictions of steady-state bacterial populations for wild-type and 
engineered strains. The engineered circuit confers a marked enhancement of bacterial growth due to 
the expression of the aerotolerance enzyme. 
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Figure 24: Comparison of  steady  state  bacterial colonization profiles 
 for wild-type and engineered strains. 
4.4 Sensitivity Analysis of Aerotolerant Bacterial Growth in Solid Tumors 
As in Chapter 3, we carried out a parametric sensitivity analysis of the model to identify which aspects 
of the mechanism are most significant in determining the targeted growth of the bacteria inside the 
tumor.  While certain aspects of the process, such as diffusion and bacterial growth rate, are likely out 
of our control, other features present themselves as design parameters. These include the strength of 
the aerotolerance enzyme, which can be altered by the choice of the specific oxidase, and the production 
and degradation rates of the aerotolerance enzyme and autoinducer, which can be altered by the choice 
of promoters, ribosome binding sites, specific luxR genes, and degradation tags. 
As performance measures of the engineered strain, we considered the overall colony size in steady 
state, represented by the area under the curve (AUC) in Figure 24, and the degree of specificity (sp) of 
the colony, represented by the width between the points at which the bacteria achieve 10% and 90% of 
their maximal concentration. An alternative performance measure, not considered here, would be the 
rate at which the bacteria disperse through the tissue. 
Local sensitivity coefficients and their derivatives are defined as Section 3.2.3 using equations (28) 
and (29).  The range of each parameter in which the system performance is sensitive was chosen by 
first exploring the range over which each individual parameter (with the others fixed at the nominal 
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values of Table 10, has an impact on system behavior. This procedure lead to upper and lower 
boundaries for each parameter.  Since the parameter values themselves are unknown, a “globalized” 
analysis was carried out in which the local sensitivity was calculated at 𝟑𝟓 =243 different points in 
parameter space, chosen by setting each parameter at the two ends of the identified range, and at the 
midpoint on the log-scale.  The sensitivity coefficients for each parameter were then averaged. 
 
Table 11: Globalized parametric sensitivities 
Parameters Range SAUC Ssp 
MA 70-130 0.1939 0.0428 
ME 70-130 0.5270 0.0404 
K 0.01-1 5.6677 0.1977 
NA 0.01-10 -0.0381 -0.0072 
NE 0.01-10 -0.0920 0.0523 
 
The results, shown in Table 11, indicate that for both performance measures the production 
parameters, MA, ME and K, play a more significant role than the degradation rates, NA and NE. (From 
the model structure, the sensitivity to Kv is the same as that to ME).  The behavior is most sensitive to 
the half-saturation constant K.  Consequently, in the design of the synthetic circuit, attention should be 
directed primarily at the choice of aerotolerance enzyme and at the production of that enzyme and of 
the autoinducer. These production processes can be controlled through, for instance, selection of 
promoters and ribosome binding sites, and choice of a form of the luxR gene which has a particular 
affinity for AHL [60]. 
 
To conclude, the analysis of the mathematical model of this process indicates that the size and 
specificity of the destructive colony can be manipulated by careful design of the processes leading to 
production of quorum-sensing autoinducer and aerotolerance enzyme.   
The modelling results in this and the previous chapter will be useful tools to guide design once the 
synthetic circuit has been finalized an it’s behavior has been confirmed. The next chapters describe 
important first steps in that direction. 
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Chapter 5 
Material and Methods 
5.1 Bacteria Strains and Plasmids 
Table 12 includes a complete list of palsmids and strains used in this study. Clostridium sporogenes 
ATCC 3584 was bought from American Type Culture Collection (Manassas, VA, USA). Clostridium 
sporogenes NCIMB 10696, E. coli S.17, and E. coli CA434 were gifts from Dr. Minton (University of 
Nottingham), Dr. Charles (University of Waterloo) and Dr. Young (Aberystwyth University) 
respectively.  
Two shuttle vectors, pJIR1457 and pMTL825x were used for conjugation. pJIR1457 was a gift from 
Dr. Rood (Monash University ) and pMTL825x from Dr. Minton  (University of Nottingham).  
Standard parts from the biobricks registry were used to construct quorum sensing plasmid: BBA-F1610, 
I1305 and BBA_F2621 were gifts from iGEM group of the University of Waterloo. Plasmid pGlow-
Xn-Pp1-CI was bought from BioCat GmbH  (Heidelberg, Germany).  
 
Table 12: List of the plasmids and the method of construction 
Strain or Plasmid 
Vector  
Relevant Characteristics 
Reference or 
source 
Bacteria Strains 
E. coli DH5α  
fhuA2 Δ(argF-lacZ)U169 phoA glnV44 Φ80 Δ(lacZ)M15 
gyrA96 recA1 relA1 endA1 thi-1 hsdR17 
New England 
Biolab (NEB) 
dam-/dcm-  
Competent E. coli 
 
ara-14 leuB6 fhuA31 lacY1 tsx78 glnV44 galK2 galT22 
mcrA dcm-6 hisG4 rfbD1 R(zgb210::Tn10) TetSendA1 
rspL136 (StrR) dam13::Tn9 (CamR) xylA-5 mtl-1 thi-1 
mcrB1 hsdR2 
New England 
Biolab (NEB) 
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One Shot® TOP10 
Chemically 
Competent E. coli 
 
F- mcrA (mrr-hsdRMS-mcrBC) 80lacZ M15 lacX74 recA1 
ara 139 (ara-leu)7697 galU galK rpsL (StrR) endA1 nupG. 
Invitrogen 
E.coli CA434 
F- hsdS2O (re, me) recAl3 ara-I4 lacy1 proA2 galK2 rpsL20 
(SmR) xyl-5 mtl-1 supE44 (A-)  (HB101 carrying R0702 
plasmid) 
R702 (Tra+ Mob+ IncP KmR TcR SmR SuR HgR) 
[91] 
E coli S.17-1 
TpR SmR recA, thi, pro, hsdR-M+RP4: 2-Tc:Mu: Km Tn7 
λpir 
[92] 
C. sporogenes  ATCC 3584 
ATCC, Manassas, 
VA, USA 
C. sporogenes NCIMB 10696 
Craibstone Estate, 
Bucksburn, 
Aberdeen. UK 
Plasmids 
BBa_F2621 
BioBrick part, designed by: Barry Canton   Group: 
Antiquity   (2004-08-09) 
[93] 
BBa_C0261 
 
BioBrick part, RBS+luxI gene [94] 
BBa_I13504 BioBrick part including  E0034, E0040, B0015 [95] 
pMTL8225x 
Shuttle vector for conjugation transform from Ecoli into 
Clostridium Developed by Dr. N. Minton 
[96] 
pJIR1475 
Shuttle vector for conjugation transform from Ecoli into 
Clostridium, developed by Dr. J. Roodi 
[97] 
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pGlow-XN-pp1-CI 
Containing anaerobic gfp (evoglow) gene downstream of thl 
promoter 
 
[98] 
pGEM®-T Easy 
Cloning vector for PCR-generated DNA fragments, AmpR 
New England 
Biolab (NEB) 
CG C0261 harboring evoglow from pGlow-XN-pp1-CI This study 
FCG 
F2621 harboring luxI and evolglow genes from C021 and 
pGlow-XN-pp1-CI 
This study 
FG F2621 harboring evoglow gene from  pGlow-XN-pp1-CI  This study 
TTG 
pGEM®-T Easy harboring evoglow and thl promoter from 
pGlow-XN-pp1-CI plasmid    
This study 
PTG 
pMTL8225x  harboring thl and evoglow from pGlow-XN-
pp1-CI 
This study 
PAgr pMTL8225x  harboring agr operon This study 
PAG2 
pMTL8225x  harboring agr operon and evoglow gene 
downstream of p2 promoter 
This study 
PAG3 
pMTL8225x  harboring agr operon and evoglow gene 
downstream of p2 promoter 
This study 
Clonejet_NoxA Clonejet vector harboring noxA gene This study 
PTN 
pMTL8225x  harboring thl promoter and noxA gene 
downstream of thl promoter 
This study 
PAGN2 
pMTL8225x  harboring agr operon, and evoglow and noxA 
genes downstream of p2 promoter 
This study 
PAGN3 
pMTL8225x  harboring agr operon, and evoglow and noxA 
genes downstream of p2 promoter 
This study 
PFCI 
pMTL8225x  harboring luxI, luxR, lux pR and lux pL from 
lux  operon, and gfp gene downstream of lux pR promoter 
This study 
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PFCG 
pMTL8225x  harboring luxI, luxR, lux pR and lux pL from 
lux  operon, and evoglow gene downstream of lux pR 
promoter 
This study 
PFCGN 
pMTL8225x  harboring luxI, luxR, lux pR and lux pL from 
lux  operon, and evoglow and noxA genes downstream of lux 
pR promoter 
This study 
5.2  Bacterial growth and storage condition 
Clostridium were grown anaerobically in an 830 anaerobic chamber (PLAS Labs). The atmosphere 
of nitrogen (N2), carbon dioxide (C02), and hydrogen (H2) was maintained at a ratio of 80% (v/v), 
10% (v/v), and 10% (v/v) respectively and at a temperature of 37°C. Clostridium were grown in TPYG 
medium (3% trypticase, 0.5% peptone, 0.1% glucose, 0.5 % yeast extract and 0.1% cysteine-HCL) or 
in TYG medium (3% trypticase, 2% yeast extract, and 0.1% sodium thioglycollate).  Whereas E. coli 
strains were grown in L-broth (1% trypticase, 0.5 % yeast extract and 1 % NaCL) and on L-agar (1.5% 
agar) at 37°C. For E. coli strains, growth culture was supplemented with 500 μg.ml-1 erythromycin, 50 
μg.ml-1 ampicillin and 100 μg.ml-1 ampicillin to counter select desired plasmid bearing bacteria.  For 
Clostridium sporogenes, antibiotics concentrations were 5 μg.ml-1 (erythromycin) and 500 μg.ml-1 (D- 
cyclocerine). 
 
E. coli and C. sporogenes were stored at -80 oC in glass cryovials containing 15% v/v and 10% v/v 
glycerol, respectively. 
 
5.3 Molecular Biology Techniques 
5.3.1 Plasmid Isolation and Manipulation 
Plasmid isolation from E. coli and gel extraction were done with miniprep kits and gel extraction kits 
from QIAGEN (Toronto, ON) or Invitrogen (Burlington, ON) by following the manufacturer’s 
instruction. Plasmid isolation from C. sporogenes was done with the standard miniprep with an added 
lysozyme step. 1 mg.ml-1 lysozyme was added to the re-suspended cell pellet, which was then incubated 
at 37°C for 10 minutes before performing cell lysis and the rest of the procedure. 
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All restriction enzymes were purchased from New England Biolab (Whitby, ON). For ligation, either 
Quick ligation kit (NEB, Whitby, ON) or T4 DNA ligase (Invitrogen or NEB) were used. Calf intestine 
alkaline phosphates were purchased from Invitrogen (Burlington, ON).  
5.3.2 PCR 
A GS4822 muti block thermo cycler (G-STORM, Somerton. Somerset, UK) was used for PCR. PCR 
reaction was prepared using Taq DNA polymerase and PCR reagents from New England Biolabs Ltd, 
(NEB, Whitby, ON) following the manufacturer’s protocol for Taq DNA Polymerase with Standard 
Taq Buffer. 
The PCR product was run on a 0.8% agarose gel and the band corresponding to the size of the product 
were cut and purified using a gel extraction kit from QIAGEN (Toronto, ON) following manufacturer’s 
instruction. 
When the PCR product includes the restriction enzyme sites, the purified PCR product was digested 
with appropriate restriction enzymes and was cloned onto the target vector using T4 DNA ligation kit 
form NEB (Whitby, ON)  . The blunt ended PCR product were cloned into vector pCRII-TOPO TA 
(Invitrogen, Burlington, ON)  using the TOPO TA cloning kit from Invitrogen or into a jet vector using 
the cloneJET PCR cloning kit (Thermo Scientific). The QuickChange Lightening Multi Site-Directed 
Mutagenesis Kit from Stratagene (La Jolla, CA) was used for changing the ribosome binding sites. 
 
The primers used in this studied were purchased from Sigma-Aldrich (Oakville, ON)  and are listed in 
Table 13  
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5.3.3 DNA Sequencing  
All sequencing was done using Applied Biosystems 3130 Genetic Analyzer (Applied Biosystems, 
Foster City, CA, USA), either at the University of Waterloo sequencing facility, or at Ottawa Hospital 
Research Institute. 
5.4 Gene Transformation Protocols 
5.4.1 Conjugation 
The protocol used for conjugation is as follows: 
The plasmid was transformed into competent E. coli CA434 cells by electroporation using a Gene 
Pulser Xcell Electrooration System (Bio-Rad Laboratories (Canada) Ltd, Mississauga, Ontario). The 
pre-set bacterial protocol for E.coli was used for a 2mm cuvette.  
The procedure for Conjugation was as follows: 
Day One:  
1. A 5 ml LB broth (with appropriate selection) with the transformed donor E. coli was inoculated .  
The culture was incubated at 37°C and 225 rpm shaking overnight. 
2. 1 ml of an appropriate anaerobic liquid growth medium (e.g. TYG) with the target C. sporogenes 
strain was inoculated and incubated at 37°C under anaerobic conditions overnight. 
Day Two: 
1. 1 ml of the overnight CA434 donor culture was pelleted by centrifugation at 8000 rpm for 1 minute.  
The supernatant was discarded and cells were washed by re-suspending in 0.5 ml sterile PBS buffer.  
The centrifugation step was repeated as before and the supernatant was discarded. 
2. The donor E. coli pellet was re-suspended in 200 μl of the overnight C. sporogenes culture to 
produce a conjugation mixture. 
3. The entire conjugation mixture was pipetted onto a single non-selective plate containing an 
appropriate anaerobic growth medium in discrete spots as illustrated in Figure 25.  
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Figure 25: Discrete spots of conjugation mixture on Agar plate 
 
4. The plate was not inverted. The plate was incubated at 37°C for 4-8 hours under anaerobic 
conditions to allow conjugal transfer of the plasmid from the E. coli donor to the C. sporogenes 
recipient. 
5. 1ml of anaerobic sterile PBS was pipetted onto the conjugation plate.  Using a sterile spreader, 
The layer of cells was scraped off the plate and was re-suspended in the PBS. 
6. Using a pipette, the cell-PBS slurry was transfered into a fresh microtube as much as possible.  
100 µl of the neat and 10-fold diluted slurry were spread onto fresh plates containing an appropriate 
anaerobic solid growth medium, supplemented with 250 µg/ml cycloserine to select against the E. coli 
conjugal donor and any other antibiotic to select for the plasmid. 
7. After incubation at 37°C for 24-72 hours colonies were large enough to pick. 
5.5 GFP Assay 
GFP intensity was measured by plate reader or spectrophotometer and spectroflurometer. 
When using a spectroflurometer and spectrophotometer, first the bacteria were grown to their 
maximum concentration and then the dilution ratio was determined to avoid saturation of the 
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spectroflurometer.  The bacteria was cultured in a 15 ml tube containing 10 ml of media and 
with an initial OD around 0.1. At each sampling time, 1 ml of bacteria was stored in a 1.5 ml 
tube. The OD was read by spectrophotometer. The bacteria were washed twice by PBS and 
were then diluted in a 1 ml cuvette by the obtained dilution factor. The fluorescent intensity 
was measured by spectroflurometer. 
 When the plate reader was used, a 500 µl bacterial culture was centrifuged, and after 
discarding the supernatant, the pellet was washed with 500 µl  PBS twice and was suspended 
in 500 µl of BPS.  Three samples of 150 µl were placed in a black 96 Well plate. A Synergy 2 
micro-mode multi-plate reader was used to measure OD600 and the fluorescent intensity of 
the samples. In order to measure the fluorescent intensity of the bacteria harboring evoglow 
gene, the excitation and emission wavelength were set to 448 µm and 496 µm, respectively. 
For bacteria harboring gfp gene from I1305, the excitation and emission wavelength were 395 
µm and 509 µm. The OD was read with absorbtion wavelength of 600 µm.  
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Chapter 6:  
Experimental Results and Discussion 
 
6.1 Introduction  
Targeting cancer cells with the minimal side effect on healthy cells and tissue is a major challenge in 
cancer therapy. By using spore forming strictly anaerobes bacteria such as Clostridium as a drug 
delivery system, anticancer drugs can be delivered to the necrotic part of a tumor but, the abnormal 
cells in more oxygenated parts remain unaffected and the tumor will regrow from this viable outer rim. 
To address this problem, we designed a genetic circuit that controls the production of an aerotolerance 
enzyme via a quorum sensing promoter. The behavior of the engineered bacteria is  the same as the 
native strain until the population density reaches a threshold. At the threshold density the genetic circuit 
is activated and the bacteria become aerotolerant.  
In order to develop a density dependent aerotolerance strain of C. sporogenes, we followed two 
routes in the experimental side of this project. First we engineered three different quorum sensing 
promoters into C. sporogenes and secondly we expressed an aerotolerance gene in C. sporogenes and 
studied the growth of the bacteria in the present of oxygen. The candidate promoters for quorum sensing 
are: the lux promoter from V. fischeri, and the P2 and P3 promoters from S. aureus (ATCC 700699). 
The behavior of these promoters had not previously been characterized in C. sporogenes. In order to 
quantify the behavior of each promoter, the noxA gene in genetic circuits proposed in Figure 21 and 22 
(section 4.1) was replaced by the green fluorescent protein (GPF) gene. As was explained in Section 
5.4, three different plasmids were constructed which contain the proposed genetic circuits. The three 
genetic circuits were cloned on the pMTL822x shuttle vector and were transformed into the E. coli 
donor strain (E. coli CA434 from the Younge lab) by electroporation. In order to transform the plasmids 
into C. sporogenes, the CA434 strains harboring the three different shuttle vectors were conjugated 
with C. sporogenes. Conjugated colonies were screened by GFP assay as described in Section 5.5. As 
the data in the following sections shows, the GFP assay revealed that the V. fischeri promoter was not 
activate in C. sporogenes, the P2 promoter exhibited constitutive activity, and the P3 promoter was 
observed to be activate at high concentration of the bacteria and exhibited a switch-like response to 
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concentration. Therefore the P3 promoter from agr operon of S. aureus appears to be the best candidate 
for implementing synthetic quorum sensing in C. sporogenes  
In order to demonstrate the effect to which the NoxA protein from C. aminuvalericum  is able to 
confer aerotolerance on C. sporogens, the noxA gene from C. aminuvalericum genome (ATCC 13725) 
was cloned in front of thl promoter and the result was cloned into the shuttle vector. The shuttle vector 
was then transform into C. sporogenes by conjugation. The growth of the engineered C. sporogenes in 
the present of oxygen was compared with native strain.  As the data in the following sections shows, 
the engineered C. sporogenes was able to grow in the presence of oxygen while the native strain could 
not. 
6.2  Construction of devices and plasmids 
Four different series of plasmids were constructed in this project, a gram negative quorum sensing 
construct, a gram positive quorum sensing construct, a constitutive construct and an aerotolerance 
construct.  The gram negative quorum sensing construct includes lux operon elements of V. fischeri 
such as the lux promoter and the luxR and luxI gene.  The gram positive quorum sensing construct 
includes the agr operon and other elements of S. aureus such as the agrA, agrB, agrC, agrD genes and 
the p2 and p3 promoters.  The constitutive construct includes the thiolase promoter (thl) which is a 
strong promoter from C. acetobotericum. The aerotolerance construct includes the noxA gene from C. 
aminovalericum.  Table 13 summarizes the list of the plasmids and the method used to construct both 
the subcloning and final plasmids. 
In order to demonstrate the behaviour of the V. fischeri quorum sensing mechanism in E. coli and C. 
sporogenes, a sender device that produces AHL and a receiver device that expresses a GFP protein in 
response to AHL were constructed. The two devices were then combined into a single genetic circuit 
to construct the final plasmid called “E. coli QS GFP” which contains all required genes and promoters 
of the V. fischeri quorum sensing (luxR, luxI, lux pR and lux pL). The behaviour of the combination of 
sender and receiver devices was compared with that of  “E. coli QS GFP” in E. coli and show similar 
behaviour. E. coli QS GFP plasmid was chosen to be transformed into C. sporogenes to investigate the 
behaviour of V. fischeri quorum sensing in C. sporogenes. In order to arrive at a construct that can 
express the reporter gene in an anaerobic system, the gfp genes from I1305 in the constructed plasmids 
were substituted with the evoglow gene from pGlow-XN-pp1-CI to construct pMTL-QS-evoglow. 
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Two different plasmids were constructed to investigate the behaviour of the P2 and P3 promoters 
(from the agr operon of S. aureus) in E. coli and C. sporogenes. These plasmids were called PAG2 and 
PAG3. The noxA gene was cloned downstream of the thl promoter to construct plasmid PTN. In order 
to quantify the production of the aerotolerance protein noxA, the gfp gene was fused into the noxA gene 
in plasmid PTGN. 
6.2.1 Sender and Receiver plasmids, and QS plasmid with reporter gene for E. coli 
Bacteria carrying the sender plasmid produce AHL; those that carry the receiver plasmid express a 
reporter gene when exposed to AHL. In order to construct receiver and sender plasmids, two Biobrick 
standard parts were chosen: BBa_F1610 and BBa_F2621. Figure 26 shows the schematic plot of these 
two plasmids.  
BBa_F1610 contains the luxI gene and BBa_F2621 contains the luxR gene and the left and right 
promoters of the lux operon (lux pR and lux pL).  Since we wanted to use these devices in gram positive 
bacteria, the first step was to change the sequence of the ribosome binding site of the luxR and luxI 
genes (AGGAGA) to those of gram positive bacteria (AGGAGG). The RBS’s were changed using PCR 
and QuikChange II Site-Directed Mutagenesis Kit. The primers used for PCR were Mut_F2621_f,  
Mut_F2621_r, Mut_F1610_f  and Mut_F1610_r. The result was validated by sequencing. 
 
 
 
 
 
 
 
 
 
 
 
In order to construct the sender device, the luxI gene with gram positive RBS was digested from 
mutated BBa_F1610 using XbaI and PstI restriction enzymes and was cloned into mutated 
plasmid BBa 1610
3987 bp
luxIEcoRI (3967)
Pst I (819)
Spe I (801)
Xba I (3982)
BBa 2621 plasmid
3237 bp
luxR
lux pL
lux pR
RBSEcoRI (3217)
Pst I (1179)
Spe I (1161)
Xba I (3232)
Figure 26:  Biobrick parts a) BBa_F1610 and b) BBa_F2621 
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BBa_F2621 at the SpeI and PstI site (XbaI and SpeI have compatible ends). Figure 27 shows the 
schematic map of the sender device 
 
Figure 27: Sender plasmid containing luxI and luxI genes with gram positive RBS 
To construct the receiver plasmid, a reporter gene was cloned downstream of the lux promoter. The 
gfp gene from Biobrick part I13504 was digested by XbaI and PstI and the resulting insert was cloned 
at the SpeI-PstI site of BBa 2621 plasmid. Figure 28 shows the schematic map of I13504 and the 
receiver plasmid. 
 
Figure 28: Schematic map of I13504 biobrick part and AHL receiver plasmid 
QS Ecoli
4043 bp
luxI
luxR
lux pR
lux pL
Stop
EcoRI (4023) HindIII (228)
Pst I (1985)
Xba I (4038)
Spe I (1967)
I13504
2954 bp
GFP
RBS
T7
EcoRI (2934) NcoI (185)
PstI (896)
SpeI (878)
XbaI (2949)
ApaLI (1327)
ApaLI (2573)
AHL Receiver
4131 bp
luxR
GFP
lux pR
lux pL
RBS
RBS
T7
EcoRI (4111)
PstI (2073)
SpeI (2055)
XbaI (4126)
XmnI (3682)
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The reporter gene (gfp) from I13504 was cloned downstream of the luxI gene in the sender plasmid 
to construct an integrated plasmid. This plasmid includes all the required lux quorum sensing elements 
and could be used to characterize the behavior of the Vibrio fischeri quorum sensing mechanism in E. 
coli. Figure 29 shows the schematic image of QS plasmid with the reporter gene.  
 
 
  
 
 
 
                        
 
 
 
 
 
 
6.2.2 Sender and receiver plasmids, and QS plasmid with reporter gene for C. 
sporogenes 
As a preliminary confirmation, the constructed plasmids were used to demonstrate the behavior of the 
V. fischeri quorum sensing mechanism in E. coli (results shown in chapter 6). To demonstrate the 
behavior of the V. fischeri quorum sensing in C. sporogenes, the genes and promoters from the plasmids 
described in Section 6.3.2 were cloned into the Pmtl8225x shuttle vector. Both receiver and sender 
plasmids were digested was digested by EcoR1 and XbaI , and the 2005 bp and 2700 bp inserts were 
subcloned into EcoR1-XbaI site of Pmtl8225x. Figure 30 shows the plasmid QS-pmtl  and QS-pmtl, 
with the GFP plasmid, that were used to implement the gram negative bacteria quorum sensing in 
Clostridium sporogenes. 
 
Ecoli QS GFP
4800 bp
luxR
GFP
LuxI
lux pR
lux pL
RBS
RBS
RBS
T7
EcoRI (4780)
PstI (2742)
SpeI (2724)
XbaI (4795)
XmnI (4351)
Figure 29: The schematic image of QS plasmids with reporter gene 
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The QS_Ecoli plamid was digested by EcoR1 and XbaI and the 2000 bp insert was subcloned into 
EcoR1-SpeI site of Pmtl8225x. Figure 30 shows the plasmid QS-pmtl. 
 
 
 
 
 
 
 
 
 
 
 
 
 
In order to construct a receiver plasmid that can be functional in Clostridium, the receiver 
plasmid was digested by EcoR1 and SpeI and the insert was cloned into EcoR1-XbaI of 
Pmtl8225x. 
 
Figure 31: Pmtl-FI, the sender plasmid for Clostridium 
pMTL FI
7427 bp
ermB
traJ
luxR
GFP
orf2
repA
lux pR
lux pL
M 13F
M 13R
RBS
RBS
pBP1 ori
ColEI RNA II
Cpa fdx terminator
T7
EcoRI (107)
PstI (1)
PstI (2237)
SpeI (1301)
SpeI (4355)
QS pMTL
7348 bp
traJ
ermB
luxR
luxI
repA
orf2
lux pL
lux pR
M13R
ColEI RNA II
pBP1 ori
Stop
EcoRI (107)
SpeI (4276)
BamHI (128)
PstI (1)
PstI (2158)
XbaI (134)
XbaI (2115)
Figure 30: QS-pmtl plasmid for transforming quorum sensing mechanism 
of gram negative bacteria into gram positive bacteria 
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Figure 31 shows the schematic image of pmt-FI, which acts as a receiver plasmid in Clostridium 
sporogenes.   
In order to implement the quorum sensing mechanism mechanism of  Vibrio fischeri into Clostridium 
sporogenes using a single plasmid, the E. coli_QS_GFP plasmid was digested by EcoR1 and XbaI and 
the 2700 bp insert was subcloned into EcoR1-XbaI site of Pmtl8225x. Figure 32 shows the schematic 
image of  pMTL_QS_GFP plasmid. 
 
 
 
 
 
 
 
 
 
 
 
 
6.2.3 Anaerobic GFP (Flavin Mononucleaotide (FMN)- based fluorescent) 
Most of the commercially available gfp genes cannot function as reporters in anaerobic systems because 
oxygen is needed for the synthesis of fluorophores. The flavin mononucleotide (FMN)-based 
fluorescent proteins (FbFPs) were developed to overcome this problem. The evoglow series from 
BioCat GmbH is a FMN-based fluorescent protein that is functional under both aerobic and anaerobic 
conditions [98]. Figure 33 shows the map of the pGlow-XN-pp1-CI (pGlow) plasmid, which contains  
the evoglow-pp1-CI (evoglow) gene which is expressed by the thl promoter. The thl promoter is a strong 
constitutive promoter for C. acetobutericum [98]. The evoglow gene originated from the Gram-positive 
pMTL_QS_GFP
8096 bp
ermBtraJ
luxR
GFP
LuxI
orf2
repA
lux pR
lux pL
M13F
M13R
RBS
RBS
RBS
pBP1 ori
ColEI RNA II
T7
Figure 32: Schematic image of PmtL_QS_GFP 
  77 
bacterium Bacillus subtilis. It was modified using codon usage optimization techniques to be expressed 
effectively in Clostridium [98]. 
 
Figure 33: Schematic map of pGlow [98] 
The evoglow gene was amplified from pGlow plasmid by PCR, using pglow_f_XbaI and 
pglow_r_pstI_spei primers. The result was inserted into a Teasy plasmid using pGEM®-T Easy Vector 
Systems from Promega to construct a Teasy-evoglow plasmid.  
6.2.4 QS plasmid with anaerobic reporter gene 
Teasy-evoglow was digested by XbaI and PstI and the resulting insert was cloned into the SpeI-PstI 
site of F1610 to construct the F1610_evoglow plasmid. This F1610_evoglow plasmid was similarly 
digested by XbaI and PstI and was cloned into the SpeI-PstI  site of F2620 plasmid to construct the 
Ecoli_QS_pglow plasmid. Finally the Ecoli_QS_pglow was digested by EcoR1 and XbaI and the 
resulting insert was cloned into the XbaI-EcoR1 site of the pMTL8225x plasmid to construct the 
pmt_QS-pglow plasmid. Figure 34 shows the schematic image of Ecoli_QS_pglow  and pmt_QS-
pglow plasmids . 
 
pGlow-XN-Pp1-Cl
5457 bp
ev oglow -Pp1-Cl
Plac
ColE1 ori
AmpR
repL
EryR
M13Rev
-10
-35
RBS
thl promoter
BamHI (459)
ClaI (4597)
EcoRI (1072)
HindIII (3709)
PstI (298)
ApaLI (1742)
ApaLI (2988)
ApaLI (3485)
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Figure 34: Schematic image of Ecoli_QS_evoglow and pMTL_QS_evoglow 
The existence of the insert was verified by sequencing the plasmids 
6.2.5 Constitutive GFP Plasmid 
To construct a positive control for Clostridium, the evoglow gene was cloned downstream of the thl 
promoter on the pMTL8225x shuttle vector. The thl promoter and evoglow gene were amplified from 
the pGlow plasmid using PCR with thl_f and pGlow_SpeI_PstI primers. The PCR product was cloned 
into the Teasy plasmid. The Teasy plasmid was digested by EcoR1 and SpeI and the resulting insert 
was cloned into the EcoR1-XbaI site of the shuttle vector to construct the Pmtl_Thl_glow plasmid.   
 
Figure 35: The schematic image of the pMTL_thl_evoglow plasmid 
Ecoli QS evoglow
4551 bp
luxR
luxI
CDS(ev oglow -Pp1-Cl) 1
lux pL
lux pR
BamHI (4059)
EcoRI (2039)
HindIII (2287)
PstI (1)SpeI (4534)
XbaI (2054)
ApaLI (432)
ApaLI (1678)
pMTL QS evoglow
7835 bp
traJ
ermB
CDS(ev oglow-Pp1-Cl) 1
luxI
luxR
repA
orf2
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Figure 35 show the schematic image of  the Pmtl_Thl_glow plasmid. The existence of the insert was 
confirmed by sequencing.  
6.2.6 Gram Negative quorum sensing mechanism with Anaerobic GFP 
To construct the receiver plasmid, the Evoglow gene was amplified by PCR from the pGlow-Xn-Pp1-
CI plasmid. Two primers, pglow_r and pglow_r, were used for PCR. The PCR product was inserted on 
pGEM®-T Easy Vector (Promega) to construct the pGEM_evoglow plasmid. The pGEM_evoglow 
plasmid was digested by XbaI and pstI and the resulting insert was cloned into the SpeI-PstI site of the 
I13504 plasmid to construct the I13504_evoglow plasmid. The I13504_evoglow plasmid was digested 
by XbaI and PstI and the resulting insert was cloned into the SpeI-PstI site of the F2621 plasmid to 
construct the FI_evoglow plasmid. Figure 36 shows schematic images of the FI_evoglow and 
I13504_evoglow plasmids. 
 
Figure 36: Schematic image of FC_evoglow and pMTL_FC_evoglow 
6.2.7 Gram Positive Quorum Sensing Mechanism with Anaerobic GFP using P2 
promoter 
To construct a plasmid with gram positive quorum sensing elements, the agr operon (~3 kbp) was 
amplified from the S. aureus (ATCC 700699 ) chromosome using GenBank sequence BA000017.4 by 
PCR with agr_r and agr_f primers which had EcoR1 and XbaI site on them respectively. 
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Figure 37: the schematic map of  agr operon on the C. acetobutericum 
As Figure 37 shows, the agr operon consists of three genes (agrA, agrB, agrC and agrD) and two 
promoters (P2 and P3).  The PCR product was digested by EcoR1 and XbaI and the resulting segment 
was cloned into the EcoR1-XbaI site of Pmtl8225x.  
 
 
Figure 38: Schematic map of pmtl_Agr plasmid 
 
Figure 38 shows the pmtl_agr plasmid, which has the agr operon on the shuttle vector.  
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In order to quantify the activity of the agr quorum sensing mechanism, the evoglow gene was fused 
downstream of the agr operon. The evoglow gene was amplified from the pGlow-Xn-Pp1-CI plasmid 
using the glow_f and glow_r primers (glow_f includes the kpnI restriction site; glow_r contains the 
XbaI site). The PCR product was digested by KpnI and XbaI and was inserted into the KpnI-XbaI site 
of Pmtl_agr plasmid. Figure 39 shows the schematic map of the resulting plasmid. 
 
 
Figure 39: Schematic map of Pmtl_agr_glow plasmid 
The existence of agr operon and evoglow gene was validated by gel electrophoresis and sequencing 
6.2.8 Gram Positive QS Mechanism with Anaerobic GFP using P3 Promoter 
The P2 and P3 promoters of the agr operon of  Staphylococcus aureus regulate RNAII and RNAIII 
transcripts, respectively.  The expression of evoglow can be controlled either by P3 promoter or  P2 
promoter. To quantitatively measure the activity of the p3 promoter in Clostridium sporogenes, the 
evoglow gene was amplified from the pGlow-Xn-Pp1-CI plasmid, using the pglow_f_XbaI and  
pglow_r_pstI_spei primers. The resulting PCR product was cloned into PGEM_T_Easy plasmid to 
construct the PGEM-T_evoglow plasmid. Figure 40 shows the schematic image of PGEM-T_evoglow 
plasmid. 
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Figure 40: Schematic image of PGEM-T_evoglow 
The PGEM-T_evoglow plasmid was digested by EcoR1 and the resulting fragment was cloned in 
the EcoR1 site of pMTL_agr plasmid to construct pMTL_agr_evoglow_p3 (.PagrG_p3) Gel 
electrophoresis image was used to pick up the right colonies.   
 
Figure 41: Schematic image of PGEM_T_evoglow and pagrG_p3 
Figure 41 shows the schematic image of PagrG_p3. Sequencing and gel electrophoresis was used to 
pick up the colony with the proper insertion.  
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6.2.9 Constitutive, gram negative and gram positive aerotolerant plasmid 
In order to put the aerotolerance enzyme (NoxA) production under the control of thl promoters and 
quorum sensing promoters of gram negative and gram positive bacteria, the noxA gene was amplified 
from the C. aminovalericum (ATCC 13725) chromosome using GenBank sequence AB219226.1 by 
PCR with primers noxA_XhoI and noxA_NheI.  
 
 
 
 
Figure 42 shows the schematic map of the PCR product.  The PCR product was cloned into a clonejet 
vector as shown in figure 43. 
 
Figure 43: Schematic image of clonejet2.1_noxA plasmid 
 
The cloneget_noxA was digested by NheI and XhoI and the resulting insert was cloned into the XhoI-
NheI sites of the pMTL_thl_evoglow, pMTL_FC_evoglow, and pMTL_agr_evoglow_p2 plasmids. 
Figure 44 shows the schematic image of the pMTL_thl_evoglow_noxA, pMTL_FC_evoglow_noxA, 
and pMTL_agr_evoglow_noxA P2 plasmids. pMTL_thl_evoglow_noxA provides constitutive 
noxA PCR
1365 bp
NoxA NheI (1358)XhoI (5)
Figure 42:   noxA gene on the chromosome of C. aminovalericum 
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expression of the aerotolerance enzyme NoxA. The evoglow reporter gene was used to quantify the 
level of the aerotolerance enzyme production. pMTL_FC_evoglow_noxA can control the expression 
of  aerotolerance enzyme by quorum sensing mechanism of gram negative bacteria (V. fischeri). 
pMTL_agr_evoglow_noxA P2 can control the expression of aerotolerance enzyme by quorum sensing 
mechanism of gram positive bacteria (S. aureus). 
 
Figure 44: Schematic image of pMTL_thl_evoglow_noxA, pMTL_FC_evoglow_noxA, and 
pMTL_agr_evoglow_noxA_P2 
6.3 Plasmid transformation into C. sporogenes  
Both electroporation and conjugation were investigated as techniques to transfer genes into C. 
sporogenes. The electroporation attempts were unsuccessful. A protocol was provided by Liu et al 
which made use of an E.coli Pulser with a capacitance of 25 μF [29]. This device was not available, 
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and so electroporation attempts were made with a Micropulser, which has a capacitance of 10 μF. The 
reduced capacitance meant that the time constant (product of the resistance and the capacitance) of the 
original protocol could not be replicated. Initially, the time constant was about 1.5 ms (much lower than 
the constant of 3 ms in the protocol). Attempts were made to increase the time constant by increasing 
the resistance, by using an electroporation buffer with lower concentration of salts, and by using a 
smaller volume of electroporation buffer. A range of concentrations of MgCl2 and Na phosphate and a 
range of sample volume were tested, but none could significantly increase the time constant. The 
highest time constant attained in these investigations was about 2 ms, which is much lower than 
prescribed in the protocol. In the last attempt, a 0.4 cm electroporation cuvette was used which brought 
the time constant to about 3 ms. Ultimately, the electroporation attempts were discontinued because it 
was determined that conjugation could be used to successfully transform plasmids into C. sporogenes. 
 
Initial attempts at conjugation were focused on C. sporogenes strain ATCC 3584. E.coli strains S.17 
and CA434 were used as the donor strains to transfer plasmid pJIR1457 and pMTL8225x into ATCC 
3584 (using the protocol outlined in Chapter 5), but the conjugative transfers were not successful. A 
subsequent round of conjugation attempts were performed with an alternative strain:  C. sporogenes 
strain NCIMB 10696. The two shuttle vectors (pMTL8225x and pJIR1457) were successfully 
transferred into Clostridium sporogenes NCIMB 10696 using E .coli CA434 as the donor strain. The 
conjugative transfer of the plasmid was confirmed by plasmid isolation from C. sporogenes. The 
transferred strain was also inoculated aerobically and no bacteria growth was observed, indicating that 
there was no E. coli contamination in transferred culture of C. sporogenes.  
National Collection of Industrial and Marine Bacteria (NCIMB) claims that C. sporogenes ATCC 
3584 is the same strain as NCIMB 10696. But these results show that ATCC 3584 is different from 
NCIMB at least in gene transformation. 
6.4 The Behaviour of a Gram Negative Quorum Sensing Mechanism in E.coli 
In order to validate the phenotype of the designed genetic circuit, we first transformed it into E. coli 
and studied the reporter gene expression as the cell density varied. 
The receiver and sender plasmids (pMTL_FI and pMTL_QS) were transformed separately into E. 
coli CA434. The receiver and sender E. coli were cultured together in a tube overnight. Figure 45 
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compares the fluorescent image of the tube containing mixed receiver and sender E. coli with the tube 
containing only the receiver E. coli. The isolated receiver E. coli did not produce GFP but the mixed 
culture shows GFP production at high bacteria concentration (OD600=1).  
 
 
 
 
 
 
 
 
 
 
 
The quorum-sensing device plasmid Pmtl_QS_GFP was transformed into E. coli CA434. The 
resulting colony showed minimal GFP expression (not visible under microscope) at low concentration, 
but when OD600 reached 1, the GFP become visible. Figure 46 shows fluorescent production of the 
lux promoter in E. coli CA434 harboring Pmtl_QS_GFP plasmid. 
 
 
 
 
 
 
 
 
 
 
 
To further validate the switch-like behavior of the quorum-sending mechanism in E. coli, fluorescent 
intensity and cell density were measured in three different strains by spectrofluorometery.  
Figure 45: a) Receiver E. coli b) Receiver E. coli mixed with sender E. coli 
 
Figure 46: The fluorescent image of the E. 
coli, which harbors 
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Three tubes of E. coli were inoculated. The first tube contained native E. coli, two other tubes 
contained the engineered E.coli harboring the QS_GFP plasmid. As a positive control, 1 mg/ml AHL 
was added to the second tube.  The bacterial concentration and the GFP intensity were measured by 
spectrophotometery and spectrofluorometery (as described in Section 5.). The results are shown in 
Figure 47.  
 
Figure 47: Comparison of GFP expression of native E. coli  with the engineered E.coli  
harboring pMTL_QS_GFP plasmid with and without AHL in the media 
 
The florescence intensity of the colony without the quorum-sensing plasmid was constant for all cell 
densities. In contrast, the florescence intensity of the colony harboring the QS plasmid (with reporter 
gene) was similar to the negative control at low densities (below OD600 of 0.9), but increased 
dramatically as the colony approached its maximal density. The transition occurred between OD600 
0.9 and 1.1, above which the florescence intensity reached a plateau. The positive control colony 
(engineered E.coli with AHL) showed a linear increase in fluorescence until OD600 of 0.45, followed 
by a plateau until OD600 of 0.9, after which it increased rapidly and reached its maximum at OD600 
of 1.1. The linear increase of fluorescence in this positive control tube can be associated with the 
activation of lux promoter by AHL. It is likely that the AHL concentration was enough to activate the 
lux promoter of bacteria up to OD 0.45, and above this population size, there was not enough AHL to 
activate lux promoters across the colony, leading to saturation. At OD600 of 0.9 the lux promoter was 
activated by the quorum-sensing mechanism, at which point the switch-like behavior was exhibited. 
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6.5 The Behaviour of Gram Negative QS Mechanism in C. sporogenes 
The pMTL_FC_evoglow (PFCG) and pMTL_FC_GFP (PFCI) plasmid were transformed into E.coli 
CA434 by electroporation and then pMTL_FC_evoglow (PFCG) was transformed into Clostridium 
sporogenes by conjugation with E. coli CA434. The fluorescence intensity and cell density of E. coli 
harboring pMTL_FC_evoglow (PFCG) and pMTL_FC_GFP (PFCI)  plasmid and C.sporogenes 
harboring pMTL_FC_evoglow (PFCG) plasmid were measured during colony growth using the method 
explained in Section 5.4.  
 
Figure 48: Florescent intensity of C.sporogenes and E. coli harboring 
pMTL_FC_evoglow(PFCG) and pMTL_QS_GFP (PFCI) plasmids 
 
As Figure 48 shows, the lux promoter was not activated in C. sporogenes, while it produced the 
expected switch-like behavior in E. coli. The fluorescence intensity of GFP (PFCI) is 6 fold higher than 
evoglow (PFCG), therefore for comparison of the behavior, the fluorescence intensities of GFP were 
divided by six. The lack of activation of lux promoter in C. sporogenes may be associated to the thick 
cell wall membrane of C. sporogenes, which does not allow AHL to freely defuse in and out of the cell. 
Another possibility is quorum sensing quenching, caused by enzymes that can hydrolyze the lactone 
bond of AHL [99]. 
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6.6 Behaviour of Gram Positive Quorum Sensing Mechanism in C. sporogenes 
6.6.1 Behavior of the P2 promoter in C. sporogenes 
The pMTL_agr_evoglow_p2 (PAG2-1) and  pMTL_thl_evoglow (PTG) plasmids were transformed 
into C. sporogenes by the conjugation method described in Section 5.4.2. The colonies recovered from 
conjugation were screened by GFP assay and gel electrophoresis of digested plasmid to select the 
transformed colonies.  To investigate the P2 promoter behavior, one colony of each type of transformed 
C. sporogenes was inoculated into a 15 ml falcon tube with 500 µg/ml D-Cyclocerine and 30 µg/ml of 
Erthromycin.   A colony of E. coli CA434 harboring pMTL_agr_evoglow_p2 (PAG2-1) was also 
inoculated aerobically with 300 µg/ml  of Erthromycin and 50 µg/ml  of Kanamycin. The fluorescence 
intensity and cell density were measured using the method described in Section 5.4. Figure 49 shows 
the fluorescence production of C. sporogenes harboring pMTL_agr_evoglow_p2 (PAG2-1),  
pMTL_thl_evoglow (PTG) with the native C. sporogenes  and the E. coli CA434 harboring 
pMTL_agr_evoglow_p2(PAG2-1).  
 
Figure 49: The behavior of the S.aureus quorum sensing mechanism with P2 promoter  
in C. sporogenes and E.coli , fluorescence intensity versus cell density  
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As the figure shows, the P2 promoter of the gram-positive quorum sensing mechanism (from 
S.aureus) does not show a switch like behavior and behaves more like a constitutive promoter in 
Clostridium sporogenes. This experiment was repeated three times with similar results. One potential 
reason for this behavior, as was reported by Koeing et.al [100], is that AgrA has a stronger affinity for 
P2 promoter in low density than P3 and a poor affinity in high density. Therefore at low density the 
low concentration of AgrA may be compensated by its strong affinity, with the result that the promoter 
shows a behavior similar to constitutive activity.  As figure 49 shows, the P2 promoter did not express 
GFP in E. coli.   It has been shown that AIP can be produced by expression of agrB and agrD in E. coli 
[101], therefore, the lack of activation of P2 promoter in E. coli could be due to the lack of AIP transport 
from cell wall by AgrB .  The constitutive plasmid (PTG) has a linear trend until OD600=1 and then 
reaches a plateau. The native bacteria shows almost constant fluorescent intensity which is due to the 
background. 
 
6.6.2 Behavior of the P3 promoter in C. sporogenes 
The Pmtl_thl_evoglow plasmid (PTG) and the pMTL_agr_evoglow_p3 plasmid were transformed 
into E. coli CA434 by electroporation to create the donor bacteria for conjugation. Plasmids were 
transformed into C. sporogenes by the conjugation method explained in Section 5.4.2. Transformation 
of the plasmids was verified by extracting the plasmid from C. sporogenes and using gel electrophoresis 
and sequencing. 
To quantify the P3 promoter behavior, C. sporogenes harboring Pmtl_thl_evoglow plasmid (PTG), 
and pMTL_agr_evoglow_p3 were inoculated into 15 ml falcon tubes with 500 µg/ml D-Cyclocerine 
and 30 µg/ml  of Erthromycin.  E.coli CA434 harboring pMTL_agr_evoglow_p3(PAG3-3) was 
inoculated aerobically with 300 µg/ml  of Erthromycin and 50 µg/ml .  The fluorescence intensity and 
cell density were measured using the method explained in Section 5.4. Two samples were used for 
measurement and the mean was calculated at each sampling point. Figure 50 shows the fluorescence 
production of C . sporogenes harboring Pmtl_thl_evoglow plasmid (PTG)and pMTL_agr_evoglow_p3 
with the native C. sporogenes  and the E.coli CA434 harboring pMTL_agr_evoglow_p3(PAG3-3). 
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Figure 50: The behavior of the S.aureus quorum sensing mechanism with P3 promoter  
in C. sporogenes and E.coli , fluorescence intensity versus cell density 
 
As the figure shows, the P3 promoter of the agr operon leads to a switch-like behavior in 
C.sporogenes. At low density (below OD600 of 0.8), the GFP intensity of the engineered strain is 
almost the same as native Clostridium. At higher density, the engineered strain exhibits much higher 
fluorescence. In contrast, the fluorescence production of the constitutive strain (positive control) is 
already significant at OD600 of 0.2. The figure also shows that the P3 promoter did not express GFP 
in E. coli.  As mentioned earlier, this may be caused by the lack of export of AIP to the outer membrane 
of the bacteria.  Finally, the wild-type Clostridium strain (negative control) shows near constant 
fluorescence through the colony growth.  
We subsequently studied the behavior of the P3 promoter in C. sporogenes in three different media: 
TYG, TYG+0.5 Glucose and ½ TYG. Figure 51 shows the result of this study.  
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Figure 51: The behavior of P3 promoter in C. sporogenes in different conditions 
Engineered C. sporogenes could not grow beyond OD 0.6 in ½ TYG, but could grow until OD 1 in 
TYG.  The bacteria could grow up to OD 1.5 in TYG+0.5 glucose suggesting that the bacteria stop 
growing in TYG because of the lack of carbon in the medium. The fluorescence intensity is fairly 
similar in all medium. The experiment also confirms the reproducibility of the result in Figure 50. 
We conclude that the agr quorum sensing mechanism of S. aurous functions in C. sporogenes and 
so can be used for application in Clostridium mediated cancer therapy. 
The P3 promoter seems to be the best candidate for expressing density dependent aerotolerance 
enzyme, but we need to show that the candidate aerotolerance gene can make C. sporogenes 
aerotolerant. In the next section the behavior of engineered C. sporogenes harboring pMTL_thl_noxA 
will be compare with native strain study in the present of oxygen.  
6.6.3 Behavior of the engineered C.sporogenes harboring aerotolerance enzyme 
expressed by thl promoter 
In order to test the hypothesis that the expression of noxA gene in C. sporogenes makes the bacteria 
aerotolerance, the pMTL_thl_noxA plasmid was transformed into C. sporogenes by conjugation, as 
explained in Section 5.4.2.  In pMTL_thl_noxA, the noxA gene is cloned downstream of the thl 
promoter to express aerotolerance enzyme constitutively.  TY medium (30 % Tryptone, 20% Yeast 
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extract) was used for aerobic growth of C. sporogenes. Sodium thioglycollate was removed from TYG 
recipe because it makes the medium anaerobic. 500 µg/ml D-Cyclocerine and 30 µg/ml of  Erthromycin 
were added to the culture of the engineered strain. Losen et al. [102] used shaking speed to control the 
oxygen concentration in the medium; a similar method was used here. The native and engineered strains 
of C. sporogenes were inoculated in two 13 ml tubes, each containing 7 ml of TY medium. We made 
the bacteria concentration in both tubes equal to OD 0.15 and kept them for 4 hours in the incubator 
without shaking, to revive their growth. Then we exposed the bacteria to different concentration of 
oxygen by changing the shaker speed. A micro plate reader was used to measure the density of the 
bacteria. Recordings of the time, bacterial concentration and shaker speed were taken at each sampling 
point. Figure 52 shows the growth of two strains at varying radial shaker speeds over time.  
 
Figure 52: Comparison the behavior of native and engineered  
C. sporogenes when exposed to oxygen    
 
The caps of both tubes were tight for the first 4 hours inside the incubator, which was set to have a 
temperature equal to 37 C. After four hours the shakers were turned on with radial speed of 225 rpm; 
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as a result both colonies started dying with about an hour delay. In order to retain their growth the radial 
speed was decreased to 160 rpm. The engineered strain recovered growth, while the native strain did 
not. Next, the shaker was turned off for two hours, to recover the growth of the native strain. The cap 
was held tight during the next 3 hours. The native strain could not retain its growth, while the engineered 
strain recovered and grew up to 0.9 OD. After 20 hrs, the cap was loosened and the shakers were turned 
on with radial speed of 225 rpm. The engineered colony retained its growth for two hours but started 
dying. Later, growth was resumed, presumably when the oxygen in the media was consumed.  
To further compare the engineered C. sporogenes with the native strain, four cultures of the 
engineered bacteria were prepared, two pair at two different concentrations of 0.8 and 0.4 OD. Two 
liquid cultures of native  were also prepared, at 0.5 and 0.2 OD. Figure 53 compares the behavior of the 
6 strains in a shaker with 225 rpm and 37C temperature. The native bacteria with OD 0.2 (blue line) 
was sealed for the first 7 hrs to reach an OD of 0.9 and then the cap was loosened.  
 
Figure 53: Comparison the behavior of native C. sporogenes   
with two different engineered strains when exposed to oxygen    
 
As the figure shows, the native and engineered strains with OD 0.5 and 0.4 could not grow but the 
engineered strain with OD around 0.8 grew to 1 OD and retained its population for 35 hours. The native 
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strain that was grown to 0.9 OD could not retain its growth after loosening the cap and started decaying 
immediately after aeration. This experiments suggests that the aerotolerance strain is capable of 
scavenging oxygen from its environment and could grow well after aeration. These results support our 
hypothesis.   
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Chapter 7:  
Conclusion and Recommendation 
7.1 Conclusion  
The main focus of this study was the development of a density dependent aerotolerant strain of C. 
sporogenes which would have the effective tumor colonization property of native bacteria at low 
density and which would be able to migrate to (and eradicate) the oxygenated part of the tumor at high 
density. Such a strain could not only solve the problem of tumor regrowth from outer oxygenated rim, 
but could also be used as a safe drug delivery system that does not affect healthy tissue. Expression of 
an aerotolerance enzyme under the control of a quorum sensing mechanism results in a strain with the 
desired properties. Key design features are the threshold population density at which bacteria becomes 
aerotolerant and the maximum concentration of the aerotolerance enzyme.  
Two well characterized quorum sensing mechanisms were chosen as candidates for this design: from 
V. fischeri (a gram negative bacteria) and S. aureus (a gram positive bacteria). The lux quorum sensing 
mechanism of  V. fischeri and the agr quorum sensing mechanism of S. aureus are regulated, 
respectively, by a small chemical called acyl homoserine lactone (AHL) and a small peptide (AIP). The 
dynamic behavior of these two mechanisms were studied by simulation of mathematical models in 
MATLAB. This analysis elucidated system dynamics, and suggested key design parameters.  
The model of the lux quorum sensing mechanism (modified from [59]) confirms that the system 
exhibits bistability and hysteresis. The genetic circuit is ‘off’ at low AHL concentration (corresponding 
to low population density) and is ‘on’ at high AHL concentration. Our investigations of the effects of 
the luxR and luxI promoter strengths and RBS revealed that any of these features can be used tune the 
threshold AHL concentration, but that the final concentration of the aerotolerance enzyme can be tuned 
only by the expression strength of  luxR. A globalized parametric sensitivity analysis showed that the 
maximal induced expression rate of LuxR and the degradation rate of luxR are the most significant 
parameters for tuning the steady-state concentration of aerotolerance enzyme, and that the threshold 
AHL concentration is most sensitive to the dissociation constant for LuxR and its degradation rate.  The 
sensitivity analysis confirmed that the dissociation constant of LuxR can be used to tune the threshold 
activation without affecting the steady state concentration. These results suggest a design protocol: the 
threshold AHL concentration can be tuned by manipulation of either the luxI expression strength 
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(promoter or RBS) or by tuning the LuxR degradation rate (with, e.g. a degradation tag). Once an 
acceptable threshold AHL concentration has been achieved, the degree of aerotolerance (determined 
by the concentration of noxA) can be tuned independently by manipulation of the LuxR expression 
strength. 
Our analysis of the Gustaffson et al. model [62]  of the agr quorum sensing of S. aureus yielded 
similar results.  Again, the system was confirmed to exhibit bistability and hysteresis: off at low AIP 
concentration and on when AIP concentration exceeds a threshold. We determined that the threshold 
AIP concentration and the final concentration of the aerotolerance enzyme both increase with the 
strength of expression of AgrA and AgrC. Our globalized sensitivity analysis revealed that the threshold 
AIP concentration is most sensitive to the Michaelis constant for activator binding, and is also highly 
sensitive to the degradation rates for AgrA and AgrC, and to the maximal activated expression rate of 
AgrC. The final value of aerotolerance enzyme is sensitive to the same parameters, except it is 
insensitive to the rate of degradation of AgrC. Once again, a design strategy is suggested: the degree of 
aerotolerance can be tuned by the degradation rate of AgrA or expression strength of AgrC, and the 
threshold AIP concentration can subsequently be independently adjusted by altering the the rate of 
degradation of AgrC. 
We complemented this model-based design of the genetic circuit with a model that simulates the 
time-varying growth of the engineered bacteria in a tumor environment (assumed, for simplicity, to be 
a radially symmetric sphere). Bacterial growth was coupled to the genetic circuit by considering a 
simplified mechanism that represents both the gram positive and the gram negative quorum sensing 
systems. Production, degradation, and diffusion of the aerotolerance enzyme were modeled.  
Simulation of this mathematical model predicted migration of the engineered bacteria to the 
oxygenated part of the tumor, while growth of the native bacteria is restricted to the hypoxic area of the 
tumor. We considered two key performance measures: the overall colony size in steady state, and the 
degree of specificity of the colony. A sensitivity analysis revealed that for both performance measures 
the production parameters are more significant than the degradation rates. The analysis suggests that 
the production rates of the aerotolerance enzyme and the autoinducer are the key design parameters that 
will allow tuning of the performance measures to desired values. 
These modelling efforts provide guides to system design, which will be useful once the performance 
of the overall system has been confirmed, and is ready for tuning.  
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We considered three candidates for the density dependent production of aerotolerance enzyme in the 
engineered Clostridium strain: the lux promoter from V. fischeri, and the P2 and P3 promoters from S. 
aureus. Three genetic circuits were constructed by putting an anaerobic reporter gene under the control 
of these promoters. Each genetic circuit contains all elements of the associated quorum sensing 
mechanism. The genetic circuits were transformed into C. sporogenes by conjugation and the 
production of the reporter gene in different cell densities were assessed. The behavior of each promoter 
was compared with positive and negative controls (constitutive expression of reporter gene and the 
native bacteria, respectively). We found that the lux promoter was not activated in C. sporogenes. The 
P2 promoter was found to show a behavior similar to the constitutive promoter in C. sporogenes (and 
was inactive in E. coli). The P3 promoter showed the desired density-dependent expression of the 
reporter gene, and so appears to be a good candidate for quorum sensing therapeutic mechanism in C. 
sporogenes.  
 
To test the hypothesis that expression of an aerotolerance enzyme can confer aerotolerance on C. 
sporogenes, the noxA gene of C. aminovalericum was cloned downstream of the thl promoter (a strong 
constitutive promoter) and the resulting plasmid was transformed into C. sporogenes. The behavior of 
the engineered C. sporogenes was compared with the native strain in the present of oxygen. We found 
that the engineered bacteria retained its growth after aeration, while the native bacteria could not grow 
in the presence of oxygen, as expected. Further experiments are needed to confirm this behavior, by 
e.g. carefully comparing growth of cultures in a range of hypoxic conditions, as measured by dissolved 
oxygen assays. Ideally, this would be followed by identification of the biochemical mechanism by 
which aerotolerance is conferred.  
7.2 Recommendation and Future Directions 
The preliminary work carried out in this project provides a solid foundation to explore the use of 
engineered C. sporogenes for tumor therapy. The next step will be to construct a strain containing the 
final product: noxA under the control of the p3 quorum-sensing promoter. That system’s performance 
can be assayed using the reporter techniques presented in Chapter 6. Once appropriate function is 
verified, biochemcial assays should be carried out to confirm our understanding of the response: the 
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AIP concentration can be measured by mass spectrometery, and the concentration of Agr mRNA and 
proteins can be measured by qPCR and western blot.  
 
Once these biochemical features of the system have been confirmed, we could begin characterization 
of the response toward therapeutic design.  This could begin with careful time-series assays of the 
response under various conditions (e.g. media, oxygen levels). This data could be used to refine the 
model (Chapter 3) of the quorum-sensing response so that it could provide predictions of the behavior 
of the p3 system. At the same time, we could explore the system’s design space, by altering the choice 
of promoters, RBS, and degradation tags, as described above. (A codon optimization exercise should 
also be carried out at this stage, as the agr and noxA genes are not native to C. sporogenes). 
 The mathematical model proposed in Chapter 4 can be expanded to include a more comprehensive 
mathematical model of the genetic circuit and the tumor microenvironment. The study of the bacteria 
migration to the tumor site and its growth in tumor before becoming aerotolerant can be included in the 
mathematical model.   
The next step would be to investigate colony behavior in an in vitro tumor microenvironment [103]. 
Again, careful time-series measurements of colony behavior will allow refinement and specialization 
of the model of colony formation (Chapter 4), which will, in turn, guide an exploration of how 
variations in the design will affect performance in terms of colony growth and tumor regression. Once 
these in vitro characterizations are successful, the next step would be to repeat these studies in an in 
vivo environment (e.g. a mouse model), with the long term goal of entering clinical studies. 
At the same time, it would be worthwhile following up with alternative designs. In particular, in our 
experiments, the lux promoter was not activate in C. sporogenes, but the reason remains unclear.  It is 
possible that AHL is successfully produced in C. sporogenes, but cannot diffuse freely across the cell 
membrane. A series of experiments could be designed to elicit the reason for the lack of activation of 
lux promoter in C. sporogenes. The first step would be to determine whether AHL is produced in C. 
sporogenes. This can be done with an enzymatic assay or a detection technique such as HPLC.  If the 
presence of the AHL is confirmed in the C. sporogenes, then the lux promoter can possibly be activated 
by expressing a receptor that facilitates export of AHL across the cell membrane. 
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Appendix A 
 
Nomenclature 
α dimensionless diffusion coefficient of AHL 
𝛽 dimensionless diffusion coefficient of aerotolance enzyme 
𝛾 dimensionless diffusion coefficient of Bacteria 
𝑨 concentration of AgrA 
𝐴𝑒 extracellular AHL concentration 
AM maximal concentration of autoinducer 
𝐴𝑝 concentration of phosphorylated AgrA 
B Concentration of AgrB 
C Concentration of AgrC 
CB bacterial concentration 
CM maximal concentration of bacteria 
𝐶𝑝 active AgrC receptor 
𝐶𝑥 inactive AgrC 
𝐷 concentration of AgrD 
DA diffusion coefficient of autoinducer  
DB diffusion coefficient of aerotolerance enzyme 
DC diffusion coefficient of bacteria 
𝑑𝐴 degradation rate for AgrA 
𝑑𝐴𝑝 degradation of phosphorylated AgrA 
𝑑𝐵 degradation rate of AgrD 
𝑑𝐶  degradation rate of AgrC 
𝑑𝑐𝑝 degradation rate of  active AgrC receptor 
𝑑𝑐𝑥 degradation rate of  inactive AgrC receptor 
𝑑𝑃 degradation rate of AIP 
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𝑬 concentration of aerotolerance enzyme 
EM maximal concentration of aerotolerance enzyme 
𝐺 concentration of GFP 
I concentration of LuxI 
Im LuxI mRNA concentration  
k half-saturation constant 
K half-saturation constant 
KA rate of production of autoinducer 
KB rate of production of bacteria 
KE rate of production of aerotolerance enzyme 
k1 association rate of LuxR and AHL 
k-1 dissociation rate of LuxR-AHL complex 
K1 ratio of the association rate 𝑘1 to the dissociation rate 𝑘−1 
k2 association rate LuxR-AHL dimer 
k-2 aissociation rate LuxR-AHL dimer 
𝐾2 ratio of association to the rate of dissociation of the dimer 
𝐾3 maximal rates for activated transcription of  Rm 
𝐾4 dissociation constants for D-promoter binding to luxR promoter 
k5 basal transcription rates for 𝑅𝑚 
k6 luxR mRNA degradation rate  
𝐾7 maximal rates for activated transcription of  Im 
𝐾8 dissociation constants for D-promoter binding to luxI promoter 
k9 basal transcription rates for 𝐼𝑚 
k10 mRNA degradation rate  
k11 per-mRNA translation rate LuxR 
k12 degradation rate of LuxR 
k13 per-mRNA translation rate LuxI 
k14 degradation rate of LuxI 
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k15 per-LuxI production rate of AHL 
k16 diffusion rate of AHL 
𝑘𝐴 
maximal rate of activated expression of AgrA 
KA. 
rate of production of autoinducer 
𝑲𝑨𝑷 Michaelis constant of activator binding of phosphorylated AgrA  
𝑘𝐴𝑝𝑟𝑖𝑚𝑒  
basal transcription rate of expression of AgrA 
𝑘𝐶  
the maximal rate of activated expression of AgrC 
𝑘𝑐1 association rate of active AgrC receptor 
𝑘𝑐2 association rate  of inactive AgrC receptor 
𝑘𝑐3 dissociation rate of active AgrC receptor 
𝑘𝑐4 dissociation rate of inactive AgrC receptor 
𝑘𝐶𝑝𝑟𝑖𝑚𝑒  basal transcription rate of AgrC 
 
𝑲𝑪𝑷 Production rate of AgrC complex with native AIP 
𝑲𝑪𝒙 Production rate of AgrC complex with inhibitor AIP 
𝑘𝑑𝑝  
dephosphorylation rate 
𝑘𝐷  the maximal rate of activated expression of AgrD 
𝑘𝐷𝑝 production rate AIP 
𝑘𝐷𝑝𝑟𝑖𝑚𝑒  basal transcription rate for AgrD 
𝒌𝒑 
phosphorylation rate 
kv 
strength of aerotolerance enzyme 
Kv 
dimensionless strength of aerotolerance enzyme 
MA 
dimensionless AHL production rate 
MB 
dimensionless bacterial growth rate 
ME dimensionless aerotolerance enzyme production rate  
NA 
dimensionless AHL degradation rate 
NB 
dimensionless bacterial death rate 
NE 
dimensionless aerotolerance enzyme degradation rate 
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O 
Oxygen concentration 
R Concentration of LuxR 
Rm LuxR mRNA concentration 
TAM 
maximal life time of autoinducer 
TEM 
maximal life time of aerotolerance enzyme 
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Appendix B 
Experimental Results 
 
Table 15: Experimental data for comparison of GFP expression of native E. coli  with the 
engineered E.coli harboring pMTL_QS_GFP plasmid with and without AHL in the media 
(Figure 47) 
Native E. coli pMTL_QS_GFP+AHL pMTL_QS_GFP 
Time(hr) OD600 Intensity Time(hr) OD600 Intensity Time(hr) OD600 Intensity 
0 0.07 28.57 0 0.17 35.6 0 0.07 52.3 
1.81 0.16 31.66 0.89 0.25 33 0.49 0.13 63.4 
2.83 0.31 29.63 0 0.17 35.6 0.95 0.2 77 
3.02 0.51 27.51 0.89 0.25 33 1.7 0.29 97 
4.06 0.68 31.97 1.35 0.35 35.8 2.8 0.46 124 
4.74 0.71 28.22 1.86 0.41 35.4 3.88 0.6 129 
5.59 0.69 27.88 2.62 0.49 37.3 4.92 0.66 121 
6.68 0.75 28.6 3.72 0.59 38.5 5.61 0.77 126 
11.1 0.85 29.2 4.79 0.69 38.9 6.44 0.82 126 
14.9 0.89 32 5.82 0.75 38.4 7.39 0.75 116 
16.3 0.91 30.79 7.25 0.8 41.4 11.9 0.95 128 
18.4 0.94 30.64 8.22 0.79 42.9 15.7 1.01 154 
20.9 0.95 32.13 8.74 0.8 45.3 16.9 1.04 176 
23.9 0.96 33.36 12.8 0.88 59.8 19.2 1.08 234 
26.5 1.02 33.44 16.6 0.97 209 21.7 1.09 235 
   17.8 1 237 24.8 1.11 273 
   20.1 1.08 345 27.4 1.16 247 
   22.6 1.11 350    
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Table 16: Experimental data for comparison of florescent intensity of C.sporogenes and E. coli 
harboring MTL_FC_evoglow(PFCG) and pMTL_QS_GFP (PFCI) plasmids (Figure 48) 
PFCG in C. 
spororogenes 
PFCI in E. coli   PFCG in E. coli 
OD600 Intensity OD600 Intensity OD600 Intensity 
0.07 1979.5 0.296 442.889 0.615667 2535 
0.2715 2037 0.411333 889.833 0.441667 1152 
0.5115 1761.5 0.5315 1245.08 0.746 3409 
0.954 2510 0.598 1605.83 0.819667 4925 
1.242 2901 0.646 1869.17 0.825 5465 
  0.763333 3185.22 0.917333 10201 
  1.039 19823.6 0.832 13132.3 
 
Table 17: Experimental data for comparison of the behavior of the S.aureus quorum sensing 
mechanism with P2 promoter in C. sporogenes and E.coli (Figure 49) 
PAG2 in  
E. coli 
PAG2 in  
C. sporogenes  
Native C.sporogenes PTG in C.sporogenes 
OD600 Intensity OD600 Intensity OD600 Intensity OD600 Intensity 
0.0473 221 0.3045 3345 0.07 1979.5 0.167 1352.5 
0.2593 779 0.572 5507 0.2715 2037 0.229 2312 
0.316 908.33 0.6805 5856.5 0.5115 1761.5 0.511 5105 
0.4013 1110 0.833 9280.5 0.954 2510 0.545 6000.5 
0.5183 1220 0.9745 11552.5 1.242 2901 0.642 7941 
0.6083 1502.7 1.028 12321    0.852 11090.5 
0.6487 1460.3 1.1625 14323.5    0.885 11067 
0.6767 1644 1.142 17072    0.919 10595.5 
0.758 2193       0.904 11049.5 
0.831 2935.7       0.95 11214.5 
      0.967 10936.5 
      1.029 11057 
      1.155 11234 
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Table 18: Experimental data for comparison of the behavior of the behavior of the S.aureus 
quorum sensing mechanism with P3 promoter in C. sporogenes and E.coli , fluorescence 
intensity versus cell density (Figure 50) 
PAG3 in  
E. coli 
PAG3 in  
C. sporogenes  
Native C.sporogenes PTG in C.sporogenes 
OD600 Intensity OD600 Intensity OD600 Intensity OD600 Intensity 
0.047667 219 0.3465 1787 0.07 1979.5 0.167 1352.5 
0.372667 825 0.5235 2008 0.2715 2037 0.229 2312 
0.495667 994.333 0.8225 3121.5 0.5115 1761.5 0.511 5105 
0.616333 1244 0.9385 4793.5 0.954 2510 0.545 6000.5 
0.655667 1200.33 1.1485 6929 1.242 2901 0.642 7941 
0.775333 1374 1.1365 7282.5    0.852 11090.5 
0.899 1451 1.162 8170    0.885 11067 
0.901333 1501 1.2675 9169    0.919 10595.5 
1.01567 1760 1.203 8575.5    0.904 11049.5 
1.05567 1902 1.4315 10196.5    0.95 11214.5 
  1.4425 11552.5   0.967 10936.5 
  1.3415 8723.5   1.029 11057 
      1.155 11234 
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Table 19: Experimental data for comparison of the behavior of P3 promoter in C. sporogenes in 
different conditions (Figure 51) 
PAG3-3   
½ TYG 
PAG3-3   
TYG  
PAG3-3 
TYG(Repeat) 
PAG3-3 
TYG+0.5% Glocuse 
OD600 Intensity OD600 Intensity OD600 Intensity OD600 Intensity 
0.3615 1545.5 0.159 740.5 0.5235 2008 0.3465 1787 
0.4435 2038 0.309 1503.5 0.588 3094 0.5235 2008 
0.4885 2155 0.568 2491.5 0.786 4296 0.8225 3121.5 
0.517 2866.5 0.5955 2976.5 0.527 2686 0.9385 4793.5 
0.208 1319 0.784 3999.5 1.0255 6623.5 1.1485 6929 
0.538 2797 0.8785 4839 0.964 5981.5 1.1365 7282.5 
0.537 2702 0.991 5045.5 0.9525 5664.5 1.162 8170 
0.5655 2777.5 1.1305 5987.5 1.071 7064 1.2675 9169 
0.473 2618.5 1.0465 6820.5 1.064 7623 1.203 8575.5 
0.541 2677 1.066 6755.5    1.4315 10196.5 
0.5645 2533.5 1.1135 6861.5    1.4425 11552.5 
   1.19333 7061.33    1.3415 8723.5 
   1.201 7194.67       
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Table 20: Comparison the behavior of native and engineered C. sporogenes when exposed to 
oxygen (Figure 52) 
Native  Engineered  
Time(hr) Native Time(hr) Intensity 
0 0.1605 0 0.1615 
1 0.1695 1 0.181 
2.75 0.1965 2.75 0.2845 
4 0.2205 4 0.3305 
5.5 0.239 5.5 0.407 
6.5 0.2545 6.5 0.369 
8.25 0.255 8.25 0.399 
9.25 0.247 9.25 0.4965 
11.25 0.236 11.25 0.3745 
13.25 0.217 13.25 0.442 
14.25 0.201 14.25 0.4335 
15.75 0.1895 15.75 0.5955 
20.25 0.1825 20.25 0.7885 
21.25 0.173 21.25 0.8825 
22.25 0.166 22.25 0.9025 
32.25 0.1625 32.25 0.5765 
34.25 0.1475 34.25 0.846 
36.25 0.1495 36.25 0.9355 
37.25 0.141 37.25 0.8975 
41.25 0.1725 41.25 0.841 
43.75 0.1385 43.75 0.721 
48 0.1605 48 0.7655 
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 Table 21: Comparison the behavior of native C. sporogenes with two different engineered 
strains when exposed to oxygen (figure 53) 
Time(hr) 
Native sealed 
up to OD 0.9 
Native  
Engineered 
#2 
Engineered 
#1 
Engineered 
#2 
Engineered 
#1 
0 0.197 0.5385 0.39 0.395 0.772 0.8365 
1 0.261 0.5505 0.53 0.539 0.8255 0.9 
2 0.41 0.6565 0.503 0.5495 0.9035 0.9595 
3 0.4825 0.6 0.516 0.5505 0.934 0.958 
4 0.6295 0.637 0.533 0.5465 0.947 0.9985 
5 0.753 0.637 0.545 0.5625 0.98 0.992 
6 0.859 0.6455 0.5465 0.5635 0.9805 0.9805 
7 0.845 0.6705 0.5365 0.568 0.979 0.9795 
8 0.93 0.639 0.5195 0.54 0.974 0.96 
10.5 0.879 0.656 0.5485 0.5765 0.9975 0.985 
13.5 0.832 0.687 0.529 0.53 1.0155 0.987 
14.5 0.7995 0.6205 0.525 0.505 0.9325 0.9585 
17 0.7865 0.6375 0.52 0.4635 1.0075 0.9435 
21 0.758 0.5935 0.5015 0.52 1.007 0.9405 
25 0.7505 0.6445 0.5375 0.51 0.967 0.976 
35 0.622 0.6025 0.369 0.3665 0.9455 0.943 
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Appendix C 
Matlab Codes for Simulation and Analysis of Aerotolerant Bacteria 
Growth in Solid Tumors 
  
function bacteria_genetic 
% ---------- Anaerobic Bacteria growth in Tumour------------ 
% Db= diffusion coefficient, 
% u= Bacteria concentration cells/um, 
% x= Tumour radious um; 
% The oxygen concentration is assumed as co=aa*x^2+bb*x+cc 
% The bacteria growth can be modeled by the following PDE 
%   In the form expected by PDEPE, the single PDE is 
% 
%   1/Db .*  D_ [u] = 1/x D_ [x*   Du/Dx   ] + [-
ko/Db*(DuDx*(2*aa*x+bb)+u/x*(4*aa*x+bb))+kb/Db*u*(1-u/um)] 
%              Dt        Dx 
%    ----         ---               ------      --------------------------
---------------------------------- 
%     c            u              f(x,t,u,Du/Dx)                  
% 
%   The equation is to hold on an interval 0 <= x <= 90 for times t >= 0. 
%   The initial bacteria concentraion is zero for radious larger than Rn( 
necrotic radious) and equal  
%   to 8000 cells/um for the necrotic part  
%   Two kinds of boundary conditions are chosen so as to show how they 
%   appear in the form expected by the solver. 
%    
%   Bacteria concentration is zero at the outer rim of tumour x=R, 
%     [u]    +     [0] .* [       Du/Dx          ] = [0] 
%  
%     ---          ---    ------------------------   --- 
%   p(0,t,u)      q(0,t)        f(0,t,u,Du/Dx)        0 
% 
%    its gradient is zero at the center of the tumour. 
% 
%   [ 0]      +     [1] .* [   Du/Dx    ] = [0] 
% 
%   --------------   ---    --------------   --- 
%      p(1,t,u)     q(1,t)   f(1,t,u,Du/Dx)   0 
  
  
m = 2; 
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x = linspace(0,90,100); 
x = linspace(0,200,200); 
t = linspace(0,20000,100); 
 %tbar=t*6.172*10^(-6); 
% tbar=t; 
% oxygen profile is as Co=aa*x'*x+bb*x+cc 
for i=1:200 
 if x(i)<=20  
     Co(i)=0; 
 elseif x(i)>=20 && x(i)<=90 
%Co(i)=aa*x(i)^2+bb*x(i)+cc; 
Co(i)=- 3.044e-005*x(i)^3 + 0.005116*x(i)^2 - 0.165*x(i) + 1.497; 
 else 
     Co(i)=Co(90); 
end 
end 
xbar=x/90; 
sol = pdepe(m,@pdex1pde,@pdex1ic,@pdex1bc,xbar,t); 
% Extract the first solution component as u.  This is not necessary 
% for a single equation, but makes a point about the form of the output. 
u=sol; 
u1 = sol(:,:,1); 
u2 = sol(:,:,2); 
u3 = sol(:,:,3); 
y=trapz(xbar(20:90),u1(end,20:90)) 
  
plot(xbar(1:100),u1(end,(1:100)),'r'); 
  
  
  
% ------------------------------------------------------------------------
-- 
  
function [c,f,s] = pdex1pde(x,t,u,DuDx) 
Db=.05;Da=.05;De=.05; 
de=.004; da=.639; 
kb=.1;ka=4.8*10^(-7);ke=0.05;kv=.15; 
kb=.1;ka=4.8*10^(-7);ke=.05; 
MB=100;MA=1;NA=.05;ME=1;NE=.05; NB=10^-10;kv=0; 
MB=20000;MA=100;NA=.001;ME=100;NE=.001; NB=18500;kv=23; 
  
x1 = linspace(0,90,100); 
% oxygen profile  
for i=1:100 
 if x1(i)<=20 
     Co1(i)=0; 
 else 
Co1(i)=- 3.044e-005*x1(i)^3 + 0.005116*x1(i)^2 - 0.165*x1(i) + 1.497; 
end 
end 
Max_Co=max(Co1); 
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x2=x*90; 
if x2<=20  
     Co=0; 
 elseif x2>=20 && x2<=90 
  
Co=- 3.044e-005*x2^3 + 0.005116*x2^2 - 0.165*x2 + 1.497; 
 else 
     Co=Max_Co; 
end 
Co2=Co/Max_Co; 
  
c = [1/.0001;1/1;1/0.1]; 
f = [1;1;1].*DuDx; 
  
 s =[MB*u(1)*(1-u(1))-NB/(1-Co2/(kv*u(3)+1)+.00000001)*u(1);MA*u(1)-
NA*u(2);ME*u(2)*u(1)-NE*u(3)]; 
  
% ------------------------------------------------------------------------
-- 
  
function u0 = pdex1ic(xbar) 
Cb0=.1; 
if xbar<(20/90) 
u0=[.1;0;0]; 
else 
u0 =[0;0;0]; 
end 
     
% ------------------------------------------------------------------------
-- 
  
function [pl,ql,pr,qr] = pdex1bc(xl,ul,xr,ur,t) 
pl = [0;0;0]; 
ql = [1;1;1]; 
pr = [ur(1);ur(2);ur(3)]; 
qr = [0;0;0]; 
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